-
2
-
-
79960063726
-
The current trend of induction and maintenance treatment in patients of different PRA levels: A report on OPTN/UNOS Kidney Transplant Registry data
-
Cai J, Terasaki P. The current trend of induction and maintenance treatment in patients of different PRA levels: a report on OPTN/UNOS Kidney Transplant Registry data. Clin Transplant 2010;45-52.
-
(2010)
Clin Transplant
, pp. 45-52
-
-
Cai, J.1
Terasaki, P.2
-
3
-
-
77951052617
-
Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology
-
20394456 1:CAS:528:DC%2BC3cXnslaqtbw%3D
-
Gaber AO, Monaco AP, Russell JA, Lebranchu Y, Mohty M. Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology. Drugs. 2010;70:691-732.
-
(2010)
Drugs
, vol.70
, pp. 691-732
-
-
Gaber, A.O.1
Monaco, A.P.2
Russell, J.A.3
Lebranchu, Y.4
Mohty, M.5
-
4
-
-
84879795558
-
Pharmacokinetic and pharmacodynamic studies of two different rabbit antithymocyte globulin dosing regimens: Results of a randomized trial
-
23507258
-
Büchler M, Longuet H, Lemoine R, Herr F, Gatault P, Thibault G, et al. Pharmacokinetic and pharmacodynamic studies of two different rabbit antithymocyte globulin dosing regimens: results of a randomized trial. Transpl Immunol. 2013;28:120-6.
-
(2013)
Transpl Immunol
, vol.28
, pp. 120-126
-
-
Büchler, M.1
Longuet, H.2
Lemoine, R.3
Herr, F.4
Gatault, P.5
Thibault, G.6
-
5
-
-
84891762978
-
Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome
-
24184682 1:CAS:528:DC%2BC2cXosVCktA%3D%3D
-
Lindemans CA, Chiesa R, Amrolia PJ, Rao K, Nikolejava O, de Wildt A, et al. Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome. Blood. 2014;123:126-32.
-
(2014)
Blood
, vol.123
, pp. 126-132
-
-
Lindemans, C.A.1
Chiesa, R.2
Amrolia, P.J.3
Rao, K.4
Nikolejava, O.5
De Wildt, A.6
-
6
-
-
77953806817
-
Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine
-
20406686 1:CAS:528:DC%2BC3cXnvVynsL4%3D
-
Morelon E, Lefrançois N, Besson C, Prévautel J, Brunet M, Touraine JL, et al. Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine. Transpl Immunol. 2010;23:53-8.
-
(2010)
Transpl Immunol
, vol.23
, pp. 53-58
-
-
Morelon, E.1
Lefrançois, N.2
Besson, C.3
Prévautel, J.4
Brunet, M.5
Touraine, J.L.6
-
8
-
-
84878951527
-
Thymoglobulin and its use in renal transplantation: A review
-
23774740 1:CAS:528:DC%2BC3sXhtVylu7nF
-
Thiyagarajan UM, Ponnuswamy A, Bagul A. Thymoglobulin and its use in renal transplantation: a review. Am J Nephrol. 2013;37:586-601.
-
(2013)
Am J Nephrol
, vol.37
, pp. 586-601
-
-
Thiyagarajan, U.M.1
Ponnuswamy, A.2
Bagul, A.3
-
9
-
-
84867599816
-
The role of Thymoglobulin induction in kidney transplantation: An update
-
23061755 1:CAS:528:DC%2BC3sXitVyksA%3D%3D
-
Mourad G, Morelon E, Noël C, Glotz D, Lebranchu Y. The role of Thymoglobulin induction in kidney transplantation: an update. Clin Transplant. 2012;26:E450-64.
-
(2012)
Clin Transplant
, vol.26
, pp. 450-E464
-
-
Mourad, G.1
Morelon, E.2
Noël, C.3
Glotz, D.4
Lebranchu, Y.5
-
10
-
-
67749113445
-
Rabbit antithymocyte globulin (thymoglobulin): A review of its use in the prevention and treatment of acute renal allograft rejection
-
19634926 1:CAS:528:DC%2BD1MXhtFGhu7jK
-
Deeks ED, Keating GM. Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection. Drugs. 2009;69:1483-512.
-
(2009)
Drugs
, vol.69
, pp. 1483-1512
-
-
Deeks, E.D.1
Keating, G.M.2
-
11
-
-
84888326839
-
A comprehensive and quantitative analysis of the major specificities in rabbit antithymocyte globulin preparations
-
24168235 1:CAS:528:DC%2BC3sXhvVGhtrzJ
-
Popow I, Leitner J, Grabmeier-Pfistershammer K, Majdic O, Zlabinger GJ, Kundi M, et al. A comprehensive and quantitative analysis of the major specificities in rabbit antithymocyte globulin preparations. Am J Transplant. 2013;13:3103-13.
-
(2013)
Am J Transplant
, vol.13
, pp. 3103-3113
-
-
Popow, I.1
Leitner, J.2
Grabmeier-Pfistershammer, K.3
Majdic, O.4
Zlabinger, G.J.5
Kundi, M.6
-
12
-
-
84890923836
-
Influence of FcγRIIIA genetic polymorphism on T-lymphocyte depletion induced by rabbit antithymocyte globulins in kidney transplant patients
-
24322002 1:CAS:528:DC%2BC3sXhvV2gs7zI
-
Ternant D, Büchler M, Thibault G, Ohresser M, Watier H, Lebranchu Y, et al. Influence of FcγRIIIA genetic polymorphism on T-lymphocyte depletion induced by rabbit antithymocyte globulins in kidney transplant patients. Pharmacogenet Genomics. 2014;24:26-34.
-
(2014)
Pharmacogenet Genomics
, vol.24
, pp. 26-34
-
-
Ternant, D.1
Büchler, M.2
Thibault, G.3
Ohresser, M.4
Watier, H.5
Lebranchu, Y.6
-
13
-
-
0345676502
-
Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation
-
9679818 1:CAS:528:DyaK1cXltFGktrc%3D
-
Gaber AO, First MR, Tesi RJ, Gaston RS, Mendez R, Mulloy LL, et al. Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation. 1998;66:29-37.
-
(1998)
Transplantation
, vol.66
, pp. 29-37
-
-
Gaber, A.O.1
First, M.R.2
Tesi, R.J.3
Gaston, R.S.4
Mendez, R.5
Mulloy, L.L.6
-
14
-
-
0031838098
-
A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients
-
9638854 1:CAS:528:DyaK1cXkt1Shsb0%3D
-
Mariat C, Alamartine E, Diab N, de Filippis JP, Laurent B, Berthoux F. A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients. Transpl Int. 1998;11:231-6.
-
(1998)
Transpl Int
, vol.11
, pp. 231-236
-
-
Mariat, C.1
Alamartine, E.2
Diab, N.3
De Filippis, J.P.4
Laurent, B.5
Berthoux, F.6
-
15
-
-
0033561405
-
A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients
-
10221486 1:CAS:528:DyaK1MXivFSkur8%3D
-
Brennan DC, Flavin K, Lowell JA, Howard TK, Shenoy S, Burgess S, et al. A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients. Transplantation. 1999;67:1011-8.
-
(1999)
Transplantation
, vol.67
, pp. 1011-1018
-
-
Brennan, D.C.1
Flavin, K.2
Lowell, J.A.3
Howard, T.K.4
Shenoy, S.5
Burgess, S.6
-
16
-
-
0035960019
-
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression
-
11579299 1:STN:280:DC%2BD3Mrjt1OktA%3D%3D
-
Mourad G, Garrigue V, Squifflet JP, Besse T, Berthoux F, Alamartine E, et al. Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. Transplantation. 2001;72:1050-5.
-
(2001)
Transplantation
, vol.72
, pp. 1050-1055
-
-
Mourad, G.1
Garrigue, V.2
Squifflet, J.P.3
Besse, T.4
Berthoux, F.5
Alamartine, E.6
-
17
-
-
0037468729
-
A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients
-
12660513 1:CAS:528:DC%2BD3sXitlyrsb0%3D
-
Charpentier B, Rostaing L, Berthoux F, Lang P, Civati G, Touraine JL, et al. A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. Transplantation. 2003;75:844-51.
-
(2003)
Transplantation
, vol.75
, pp. 844-851
-
-
Charpentier, B.1
Rostaing, L.2
Berthoux, F.3
Lang, P.4
Civati, G.5
Touraine, J.L.6
-
18
-
-
0036933592
-
A prospective randomized controlled study on the efficacy and tolerance of two antilymphocytic globulins in the prevention of rejection in first-heart transplant recipients
-
12072903 1:CAS:528:DC%2BD38XlvFOmsro%3D
-
Schnetzler B, Leger P, Völp A, Dorent R, Pavie A, Gandjbakhch I. A prospective randomized controlled study on the efficacy and tolerance of two antilymphocytic globulins in the prevention of rejection in first-heart transplant recipients. Transpl Int. 2002;15:317-25.
-
(2002)
Transpl Int
, vol.15
, pp. 317-325
-
-
Schnetzler, B.1
Leger, P.2
Völp, A.3
Dorent, R.4
Pavie, A.5
Gandjbakhch, I.6
-
19
-
-
0037084271
-
Short course induction immunosuppression with thymoglobulin for renal transplant recipients
-
11884948 1:CAS:528:DC%2BD38XntlSgtrY%3D
-
Agha IA, Rueda J, Alvarez A, Singer GG, Miller BW, Flavin K, et al. Short course induction immunosuppression with thymoglobulin for renal transplant recipients. Transplantation. 2002;73:473-5.
-
(2002)
Transplantation
, vol.73
, pp. 473-475
-
-
Agha, I.A.1
Rueda, J.2
Alvarez, A.3
Singer, G.G.4
Miller, B.W.5
Flavin, K.6
-
20
-
-
0141813546
-
A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients
-
14501856 1:CAS:528:DC%2BD3sXnsVKis7Y%3D
-
Goggins WC, Pascual MA, Powelson JA, Magee C, Tolkoff-Rubin N, Farrell ML, et al. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation. 2003;76:798-802.
-
(2003)
Transplantation
, vol.76
, pp. 798-802
-
-
Goggins, W.C.1
Pascual, M.A.2
Powelson, J.A.3
Magee, C.4
Tolkoff-Rubin, N.5
Farrell, M.L.6
-
21
-
-
33745713646
-
Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation
-
16827679 1:CAS:528:DC%2BD28XptFWkt7w%3D
-
Wong W, Agrawal N, Pascual M, Anderson DC, Hirsch HH, Fujimoto K, et al. Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation. Transpl Int. 2006;19:629-35.
-
(2006)
Transpl Int
, vol.19
, pp. 629-635
-
-
Wong, W.1
Agrawal, N.2
Pascual, M.3
Anderson, D.C.4
Hirsch, H.H.5
Fujimoto, K.6
-
22
-
-
48649088099
-
Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: An interim report
-
Stevens RB, Mercer DF, Grant WJ, Freifeld AG, Lane JT, Groggel GC, et al. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report. Transplantation. 2008;82:1391-9.
-
(2008)
Transplantation
, vol.82
, pp. 1391-1399
-
-
Stevens, R.B.1
Mercer, D.F.2
Grant, W.J.3
Freifeld, A.G.4
Lane, J.T.5
Groggel, G.C.6
-
23
-
-
0034653656
-
Low dose antithymocyte globulins in renal transplantation: Daily versus intermittent administration based on T-cell monitoring
-
10755529 1:CAS:528:DC%2BD3cXis1Cgt70%3D
-
Djamali A, Turc-Baron C, Portales P, Leverson G, Chong G, Clot J, et al. Low dose antithymocyte globulins in renal transplantation: daily versus intermittent administration based on T-cell monitoring. Transplantation. 2000;69:799-805.
-
(2000)
Transplantation
, vol.69
, pp. 799-805
-
-
Djamali, A.1
Turc-Baron, C.2
Portales, P.3
Leverson, G.4
Chong, G.5
Clot, J.6
-
24
-
-
33750713302
-
Thymoglobulin Induction Study Group. Rabbit antithymocyte globulin versus basiliximab in renal transplantation
-
Thymoglobulin Induction Study Group 17093248 1:CAS:528:DC%2BD28XhtFymur7E
-
Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D. Thymoglobulin Induction Study Group. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med. 2006;355:1967-77.
-
(2006)
N Engl J Med
, vol.355
, pp. 1967-1977
-
-
Brennan, D.C.1
Daller, J.A.2
Lake, K.D.3
Cibrik, D.4
Del Castillo, D.5
-
25
-
-
0030711092
-
Single center experience with thymoglobulin in renal transplantation
-
9366924 1:STN:280:DyaK1c%2FjtlOiuw%3D%3D
-
Zaltzman JS, Paul LC. Single center experience with thymoglobulin in renal transplantation. Transplant Proc. 1997;29:27S-8S.
-
(1997)
Transplant Proc
, vol.29
, pp. 27S-28S
-
-
Zaltzman, J.S.1
Paul, L.C.2
-
26
-
-
10744224633
-
Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation: A 1-yr follow-up of safety and efficacy
-
French Thymoglobuline Pharmacovigilance Study Group 14756271
-
Büchler M, Hurault de Ligny B, Madec C, Lebranchu Y. French Thymoglobuline Pharmacovigilance Study Group. Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation: a 1-yr follow-up of safety and efficacy. Clin Transplant. 2003;17:539-45.
-
(2003)
Clin Transplant
, vol.17
, pp. 539-545
-
-
Büchler, M.1
Hurault De Ligny, B.2
Madec, C.3
Lebranchu, Y.4
-
27
-
-
0030920481
-
Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin
-
9193840 1:STN:280:DyaK2szjslSqug%3D%3D
-
Guttmann RD, Flemming C. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin. Clin Transplant. 1997;11:185-92.
-
(1997)
Clin Transplant
, vol.11
, pp. 185-192
-
-
Guttmann, R.D.1
Flemming, C.2
-
28
-
-
16244423303
-
Induction therapy with basiliximab versus Thymoglobulin in African-American kidney transplant recipients
-
15785379 1:CAS:528:DC%2BD2MXis1entLY%3D
-
Haririan A, Morawski K, Sillix DH, El-Amm JM, Garnick J, West MS, et al. Induction therapy with basiliximab versus Thymoglobulin in African-American kidney transplant recipients. Transplantation. 2005;79:716-21.
-
(2005)
Transplantation
, vol.79
, pp. 716-721
-
-
Haririan, A.1
Morawski, K.2
Sillix, D.H.3
El-Amm, J.M.4
Garnick, J.5
West, M.S.6
-
29
-
-
0031930886
-
Advantage of antithymocyte globulin induction in sensitized kidney recipients: A randomized prospective study comparing induction with and without antithymocyte globulin
-
9550651 1:STN:280:DyaK1c3htVShsA%3D%3D
-
Thibaudin D, Alamartine E, de Filippis JP, Diab N, Laurent B, Berthoux F. Advantage of antithymocyte globulin induction in sensitized kidney recipients: a randomized prospective study comparing induction with and without antithymocyte globulin. Nephrol Dial Transplant. 1998;13:711-5.
-
(1998)
Nephrol Dial Transplant
, vol.13
, pp. 711-715
-
-
Thibaudin, D.1
Alamartine, E.2
De Filippis, J.P.3
Diab, N.4
Laurent, B.5
Berthoux, F.6
-
30
-
-
77954123600
-
Hematologic adverse effects of 2 different polyclonal antilymphocyte preparations in de novo kidney transplant patients
-
20565376
-
Rostaing L, Lavayssière L, Kamar N. Hematologic adverse effects of 2 different polyclonal antilymphocyte preparations in de novo kidney transplant patients. Exp Clin Transplant. 2010;8:178-80.
-
(2010)
Exp Clin Transplant
, vol.8
, pp. 178-180
-
-
Rostaing, L.1
Lavayssière, L.2
Kamar, N.3
-
31
-
-
84863392279
-
Comparison between thymoglobulin and ATGAM as an induction agent in adult kidney transplantation: A single-center experience
-
22310607 1:CAS:528:DC%2BC38XhvVCgu7k%3D
-
Kim JM, Jang HR, Ko JS, Kwon CH, Kwak MS, Hur WS, et al. Comparison between thymoglobulin and ATGAM as an induction agent in adult kidney transplantation: a single-center experience. Transplant Proc. 2012;44:171-4.
-
(2012)
Transplant Proc
, vol.44
, pp. 171-174
-
-
Kim, J.M.1
Jang, H.R.2
Ko, J.S.3
Kwon, C.H.4
Kwak, M.S.5
Hur, W.S.6
-
32
-
-
84897023520
-
Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients
-
24531846 1:CAS:528:DC%2BC2cXkslCmt7k%3D 4106033
-
Brokhof MM, Sollinger HW, Hager DR, Muth BL, Pirsch JD, Fernandez LA, et al. Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients. Transplantation. 2014;97:612-7.
-
(2014)
Transplantation
, vol.97
, pp. 612-617
-
-
Brokhof, M.M.1
Sollinger, H.W.2
Hager, D.R.3
Muth, B.L.4
Pirsch, J.D.5
Fernandez, L.A.6
-
33
-
-
84859705461
-
Alemtuzumab as compared to alternative contemporary induction regimens
-
22394259 1:CAS:528:DC%2BC38XpsVKgsr8%3D 3665410
-
LaMattina JC, Mezrich JD, Hofmann RM, Foley DP, D'Alessandro AM, Sollinger HW, et al. Alemtuzumab as compared to alternative contemporary induction regimens. Transpl Int. 2012;25:518-26.
-
(2012)
Transpl Int
, vol.25
, pp. 518-526
-
-
Lamattina, J.C.1
Mezrich, J.D.2
Hofmann, R.M.3
Foley, D.P.4
D'Alessandro, A.M.5
Sollinger, H.W.6
-
34
-
-
84874810414
-
Comparison of long-term effect of thymoglobulin treatment in patients with a high risk of delayed graft function
-
23026612
-
Requião-Moura LR, Ferraz E, Matos AC, Tonato EJ, Ozaki KS, Durão MS, et al. Comparison of long-term effect of thymoglobulin treatment in patients with a high risk of delayed graft function. Transplant Proc. 2012;44:2428-33.
-
(2012)
Transplant Proc
, vol.44
, pp. 2428-2433
-
-
Requião-Moura, L.R.1
Ferraz, E.2
Matos, A.C.3
Tonato, E.J.4
Ozaki, K.S.5
Durão, M.S.6
-
35
-
-
80055017102
-
Induction antibody therapy in renal transplantation using early steroid withdrawal: Long-term results comparing anti-IL2 receptor and anti-thymocyte globulin
-
21835269
-
Libório AB, Mendoza TR, Esmeraldo RM, Oliveira ML, Paes FJ, Silva Junior GB, et al. Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin. Int Immunopharmacol. 2011;11:1832-6.
-
(2011)
Int Immunopharmacol
, vol.11
, pp. 1832-1836
-
-
Libório, A.B.1
Mendoza, T.R.2
Esmeraldo, R.M.3
Oliveira, M.L.4
Paes, F.J.5
Silva Junior, G.B.6
-
36
-
-
20544470400
-
A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients-an interim analysis
-
15888064 1:CAS:528:DC%2BD2MXmtFKitLk%3D
-
Kandaswamy R, Melancon JK, Dunn T, Tan M, Casingal V, Humar A, et al. A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients-an interim analysis. Am J Transplant. 2005;5:1529-36.
-
(2005)
Am J Transplant
, vol.5
, pp. 1529-1536
-
-
Kandaswamy, R.1
Melancon, J.K.2
Dunn, T.3
Tan, M.4
Casingal, V.5
Humar, A.6
-
37
-
-
0035035308
-
Steroid-free immunosuppression in renal transplantation: A long-term follow-up of 100 consecutive patients
-
11374407 1:STN:280:DC%2BD3M3ptFOgtQ%3D%3D
-
Birkeland SA. Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients. Transplantation. 2001;71:1089-90.
-
(2001)
Transplantation
, vol.71
, pp. 1089-1090
-
-
Birkeland, S.A.1
-
38
-
-
8644248925
-
Rapid discontinuation of prednisone in higher-risk kidney transplant recipients
-
15548981
-
Khwaja K, Asolati M, Harmon JV, Melancon JK, Dunn TB, Gillingham KJ, et al. Rapid discontinuation of prednisone in higher-risk kidney transplant recipients. Transplantation. 2004;78:1397-9.
-
(2004)
Transplantation
, vol.78
, pp. 1397-1399
-
-
Khwaja, K.1
Asolati, M.2
Harmon, J.V.3
Melancon, J.K.4
Dunn, T.B.5
Gillingham, K.J.6
-
39
-
-
33644673045
-
Prednisone-free maintenance immunosuppression: A 5-year experience
-
16162197
-
Matas AJ, Kandaswamy R, Gillingham KJ, McHugh L, Ibrahim H, Kasiske B, et al. Prednisone-free maintenance immunosuppression: a 5-year experience. Am J Transplant. 2005;5:2473-8.
-
(2005)
Am J Transplant
, vol.5
, pp. 2473-2478
-
-
Matas, A.J.1
Kandaswamy, R.2
Gillingham, K.J.3
McHugh, L.4
Ibrahim, H.5
Kasiske, B.6
-
40
-
-
33745186177
-
Acute rejection risk in kidney transplant recipients on steroid-avoidance immunosuppression receiving induction with either antithymocyte globulin or basiliximab
-
16797289 1:CAS:528:DC%2BD28XlvFGnu78%3D
-
Heilman RL, Reddy KS, Mazur MJ, Moss AA, Post DJ, Petrides S, et al. Acute rejection risk in kidney transplant recipients on steroid-avoidance immunosuppression receiving induction with either antithymocyte globulin or basiliximab. Transplant Proc. 2006;38:1307-13.
-
(2006)
Transplant Proc
, vol.38
, pp. 1307-1313
-
-
Heilman, R.L.1
Reddy, K.S.2
Mazur, M.J.3
Moss, A.A.4
Post, D.J.5
Petrides, S.6
-
41
-
-
55449124588
-
Astellas Corticosteroid Withdrawal Study Group. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy
-
18936569
-
Woodle ES, First MR, Pirsch J, Shihab F, Gaber AO, Van Veldhuisen P. Astellas Corticosteroid Withdrawal Study Group. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg. 2008;248:564-77.
-
(2008)
Ann Surg
, vol.248
, pp. 564-577
-
-
Woodle, E.S.1
First, M.R.2
Pirsch, J.3
Shihab, F.4
Gaber, A.O.5
Van Veldhuisen, P.6
-
42
-
-
27544473842
-
Preliminary results with early corticosteroid withdrawal in African American renal allograft recipients
-
16269308
-
Gruber SA, West MS, Sillix DH, El-Amm JM, Garnick J, Morawski K, et al. Preliminary results with early corticosteroid withdrawal in African American renal allograft recipients. Surgery. 2005;138:772-8.
-
(2005)
Surgery
, vol.138
, pp. 772-778
-
-
Gruber, S.A.1
West, M.S.2
Sillix, D.H.3
El-Amm, J.M.4
Garnick, J.5
Morawski, K.6
-
43
-
-
33748485176
-
Short-term experience with early steroid withdrawal in African-American renal transplant recipients
-
16869806 1:CAS:528:DC%2BD28XhtFGqsrbI
-
Haririan A, Sillix DH, Morawski K, El-Amm JM, Garnick J, Doshi MD, et al. Short-term experience with early steroid withdrawal in African-American renal transplant recipients. Am J Transplant. 2006;6:2396-402.
-
(2006)
Am J Transplant
, vol.6
, pp. 2396-2402
-
-
Haririan, A.1
Sillix, D.H.2
Morawski, K.3
El-Amm, J.M.4
Garnick, J.5
Doshi, M.D.6
-
44
-
-
33846680173
-
Early steroid withdrawal therapy in renal transplant recipients: A steroid-free sirolimus and Cell Cept-based calcineurin inhibitor-minimization protocol
-
17302598
-
Jaber JJ, Feustel PJ, Elbahloul O, Conti AD, Gallichio MH, Conti DJ. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and Cell Cept-based calcineurin inhibitor-minimization protocol. Clin Transplant. 2007;21:101-9.
-
(2007)
Clin Transplant
, vol.21
, pp. 101-109
-
-
Jaber, J.J.1
Feustel, P.J.2
Elbahloul, O.3
Conti, A.D.4
Gallichio, M.H.5
Conti, D.J.6
-
45
-
-
18044399260
-
Rapid discontinuation of steroids in living donor kidney transplantation: A pilot study
-
12102262 1:STN:280:DC%2BD38zlvVansw%3D%3D
-
Matas AJ, Ramcharan T, Paraskevas S, Gillingham KJ, Dunn DL, Gruessner RW, et al. Rapid discontinuation of steroids in living donor kidney transplantation: a pilot study. Am J Transplant. 2001;1:278-83.
-
(2001)
Am J Transplant
, vol.1
, pp. 278-283
-
-
Matas, A.J.1
Ramcharan, T.2
Paraskevas, S.3
Gillingham, K.J.4
Dunn, D.L.5
Gruessner, R.W.6
-
46
-
-
33748674845
-
Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression
-
16968478
-
Rajab A, Pelletier RP, Henry ML, Ferguson RM. Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression. Clin Transplant. 2006;20:537-46.
-
(2006)
Clin Transplant
, vol.20
, pp. 537-546
-
-
Rajab, A.1
Pelletier, R.P.2
Henry, M.L.3
Ferguson, R.M.4
-
47
-
-
19244366185
-
Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy
-
12095056 1:CAS:528:DC%2BD38XivFyjs7c%3D
-
Lebranchu Y, Bridoux F, Büchler M, Le Meur Y, Etienne I, Toupance O, et al. Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy. Am J Transplant. 2002;2:48-56.
-
(2002)
Am J Transplant
, vol.2
, pp. 48-56
-
-
Lebranchu, Y.1
Bridoux, F.2
Büchler, M.3
Le Meur, Y.4
Etienne, I.5
Toupance, O.6
-
48
-
-
77954088420
-
Thymoglobulin induction and sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids
-
20386144 1:CAS:528:DC%2BC3cXns1ymu7s%3D
-
Glotz D, Charpentier B, Abramovicz D, Lang P, Rostaing L, Rifle G, et al. Thymoglobulin induction and sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids. Transplantation. 2010;89:1511-7.
-
(2010)
Transplantation
, vol.89
, pp. 1511-1517
-
-
Glotz, D.1
Charpentier, B.2
Abramovicz, D.3
Lang, P.4
Rostaing, L.5
Rifle, G.6
-
49
-
-
35248844442
-
SPIESSER Group. Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids
-
17868057
-
Büchler M, Caillard S, Barbier S, Thervet E, Toupance O, Mazouz H, et al. SPIESSER Group. Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids. Am J Transplant. 2007;7:2522-31.
-
(2007)
Am J Transplant
, vol.7
, pp. 2522-2531
-
-
Büchler, M.1
Caillard, S.2
Barbier, S.3
Thervet, E.4
Toupance, O.5
Mazouz, H.6
-
50
-
-
33644889043
-
Complete avoidance of calcineurin inhibitors in renal transplantation: A randomized trial comparing sirolimus and tacrolimus
-
16468960 1:CAS:528:DC%2BD28Xit12gt78%3D
-
Larson TS, Dean PG, Stegall MD, Griffin MD, Textor SC, Schwab TR, et al. Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant. 2006;6:514-22.
-
(2006)
Am J Transplant
, vol.6
, pp. 514-522
-
-
Larson, T.S.1
Dean, P.G.2
Stegall, M.D.3
Griffin, M.D.4
Textor, S.C.5
Schwab, T.R.6
-
51
-
-
2342596401
-
Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation
-
15114090 1:CAS:528:DC%2BD2cXksFOkurg%3D
-
Lo A, Egidi MF, Gaber LW, Amiri HS, Vera S, Nezakatgoo N, et al. Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation. Transplantation. 2004;77:1228-35.
-
(2004)
Transplantation
, vol.77
, pp. 1228-1235
-
-
Lo, A.1
Egidi, M.F.2
Gaber, L.W.3
Amiri, H.S.4
Vera, S.5
Nezakatgoo, N.6
-
52
-
-
0347812744
-
Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft
-
Grinyó JM, Gil-Vernet S, Seron D, Hueso M, Fulladosa X, Cruzado JM, et al. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft. Nephrol Dial Transplant. 1998;13:2061-4.
-
(1998)
Nephrol Dial Transplant
, vol.13
, pp. 2061-2064
-
-
Grinyó, J.M.1
Gil-Vernet, S.2
Seron, D.3
Hueso, M.4
Fulladosa, X.5
Cruzado, J.M.6
-
53
-
-
33645377235
-
Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in renal transplantation
-
16573545 1:CAS:528:DC%2BD28XkvFKgtLY%3D
-
Alexander JW, Goodman HR, Cardi M, Austin J, Goel S, Safdar S, et al. Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in renal transplantation. Transpl Int. 2006;19:295-302.
-
(2006)
Transpl Int
, vol.19
, pp. 295-302
-
-
Alexander, J.W.1
Goodman, H.R.2
Cardi, M.3
Austin, J.4
Goel, S.5
Safdar, S.6
-
54
-
-
0033814757
-
Prevention of acute rejection with antithymocyte globulin, avoiding corticosteroids, and delaying cyclosporin after renal transplantation
-
11007839 1:CAS:528:DC%2BD3cXnvV2ltr0%3D
-
Cantarovich D, Giral-Classe M, Hourmant M, Dantal J, Blancho G, Lerat L, et al. Prevention of acute rejection with antithymocyte globulin, avoiding corticosteroids, and delaying cyclosporin after renal transplantation. Nephrol Dial Transplant. 2000;15:1673-6.
-
(2000)
Nephrol Dial Transplant
, vol.15
, pp. 1673-1676
-
-
Cantarovich, D.1
Giral-Classe, M.2
Hourmant, M.3
Dantal, J.4
Blancho, G.5
Lerat, L.6
-
55
-
-
0043123394
-
A pilot protocol of a calcineurin-inhibitor free regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function
-
12795665
-
Shaffer D, Langone A, Nylander WA, Goral S, Kizilisik AT, Helderman JH. A pilot protocol of a calcineurin-inhibitor free regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function. Clin Transplant. 2003;17(Suppl 9):31-4.
-
(2003)
Clin Transplant
, vol.17
, Issue.9
, pp. 31-34
-
-
Shaffer, D.1
Langone, A.2
Nylander, W.A.3
Goral, S.4
Kizilisik, A.T.5
Helderman, J.H.6
-
56
-
-
84870688558
-
A CD3+ count-based thymoglobulin induction regimen permits delayed introduction of calcineurin inhibitors in kidney transplantation
-
22672562
-
Wang CJ, Tuffaha A, Zhang D, Diederich DA, Wetmore JB. A CD3+ count-based thymoglobulin induction regimen permits delayed introduction of calcineurin inhibitors in kidney transplantation. Clin Transplant. 2012;26:900-9.
-
(2012)
Clin Transplant
, vol.26
, pp. 900-909
-
-
Wang, C.J.1
Tuffaha, A.2
Zhang, D.3
Diederich, D.A.4
Wetmore, J.B.5
-
57
-
-
79953193081
-
Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy
-
21440735 1:CAS:528:DC%2BC3MXjvVOqtbo%3D
-
Laftavi MR, Patel S, Soliman MR, Alnimri M, Kohli R, Said M, et al. Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy. Transplant Proc. 2011;43:466-8.
-
(2011)
Transplant Proc
, vol.43
, pp. 466-468
-
-
Laftavi, M.R.1
Patel, S.2
Soliman, M.R.3
Alnimri, M.4
Kohli, R.5
Said, M.6
-
58
-
-
0037469018
-
Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy
-
12717237 1:CAS:528:DC%2BD3sXjt1alt7w%3D
-
Eason JD, Nair S, Cohen AJ, Blazek JL, Loss GE Jr. Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy. Transplantation. 2003;75:1396-9.
-
(2003)
Transplantation
, vol.75
, pp. 1396-1399
-
-
Eason, J.D.1
Nair, S.2
Cohen, A.J.3
Blazek, J.L.4
Loss, G.E.5
-
59
-
-
84910150901
-
Prospective randomized study of low dose antithymocyte globulin as induction in non sensitized adult renal transplant recipients [abstract no. 1351]
-
Grafals M, Simpson M, Gilligan H, Pomposelli J, Akoad M, Kwaja K, et al. Prospective randomized study of low dose antithymocyte globulin as induction in non sensitized adult renal transplant recipients [abstract no. 1351]. Am J Transplant. 2013;13 Suppl 5.
-
(2013)
Am J Transplant
, vol.13
, Issue.5
-
-
Grafals, M.1
Simpson, M.2
Gilligan, H.3
Pomposelli, J.4
Akoad, M.5
Kwaja, K.6
-
60
-
-
84902171857
-
Outcome and cost analysis of induction immunosuppression with IL2Mab or ATG in DCD kidney transplants
-
24573113 1:CAS:528:DC%2BC2cXpsVegu74%3D
-
Popat R, Syed A, Puliatti C, Cacciola R. Outcome and cost analysis of induction immunosuppression with IL2Mab or ATG in DCD kidney transplants. Transplantation. 2014;97:1161-5.
-
(2014)
Transplantation
, vol.97
, pp. 1161-1165
-
-
Popat, R.1
Syed, A.2
Puliatti, C.3
Cacciola, R.4
-
61
-
-
79953206620
-
Obesity in renal transplantation: The role of induction therapy on long-term outcomes
-
21440736 1:STN:280:DC%2BC3MzgtlCluw%3D%3D
-
Patel S, Pankewycz O, Kohli R, Said M, Alnimri M, Feng L, et al. Obesity in renal transplantation: the role of induction therapy on long-term outcomes. Transplant Proc. 2011;43:469-71.
-
(2011)
Transplant Proc
, vol.43
, pp. 469-471
-
-
Patel, S.1
Pankewycz, O.2
Kohli, R.3
Said, M.4
Alnimri, M.5
Feng, L.6
-
62
-
-
79960084370
-
Single-dose thymoglobulin induction in living-donor renal transplantation
-
21716186 1:CAS:528:DC%2BC3MXhtFWjt7zF
-
Schenker P, Ozturk A, Vonend O, Krüger B, Jazra M, Wunsch A, et al. Single-dose thymoglobulin induction in living-donor renal transplantation. Ann Transplant. 2011;16:50-8.
-
(2011)
Ann Transplant
, vol.16
, pp. 50-58
-
-
Schenker, P.1
Ozturk, A.2
Vonend, O.3
Krüger, B.4
Jazra, M.5
Wunsch, A.6
-
63
-
-
22144475118
-
Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pre-treatment and hepatitis C virus recurrence in liver transplantation
-
16003226
-
De Ruvo N, Cucchetti A, Lauro A, Masetti M, Cautero N, Di Benedetto F, et al. Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pre-treatment and hepatitis C virus recurrence in liver transplantation. Transplantation. 2005;80:8-12.
-
(2005)
Transplantation
, vol.80
, pp. 8-12
-
-
De Ruvo, N.1
Cucchetti, A.2
Lauro, A.3
Masetti, M.4
Cautero, N.5
Di Benedetto, F.6
-
64
-
-
0037093373
-
Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3 + lymphocyte counts in kidney and kidney-pancreas transplant recipients
-
12023634
-
Peddi VR, Bryant M, Roy-Chaudhury P, Woodle ES, First MR. Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3 + lymphocyte counts in kidney and kidney-pancreas transplant recipients. Transplantation. 2002;73:1514-8.
-
(2002)
Transplantation
, vol.73
, pp. 1514-1518
-
-
Peddi, V.R.1
Bryant, M.2
Roy-Chaudhury, P.3
Woodle, E.S.4
First, M.R.5
-
65
-
-
20444398138
-
Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat)
-
15949731
-
Koch A, Daniel V, Dengler TJ, Schnabel PA, Hagl S, Sack FU. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat). J Heart Lung Transplant. 2005;24:708-13.
-
(2005)
J Heart Lung Transplant
, vol.24
, pp. 708-713
-
-
Koch, A.1
Daniel, V.2
Dengler, T.J.3
Schnabel, P.A.4
Hagl, S.5
Sack, F.U.6
-
66
-
-
84910140676
-
Small thymoglobulin dose adjustments have profound impact on early rejections in renal transplantation [abstract no. 389]
-
Tsapepas D, Mohan S, Crew RJ, Cohen D, Ratner LE. Small thymoglobulin dose adjustments have profound impact on early rejections in renal transplantation [abstract no. 389]. Am J Transplant 2011;11 Suppl 2.
-
(2011)
Am J Transplant
, vol.11
, Issue.2
-
-
Tsapepas, D.1
Mohan, S.2
Crew, R.J.3
Cohen, D.4
Ratner, L.E.5
-
67
-
-
84880070494
-
Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients
-
23432665
-
Khanmoradi K, Knorr JP, Feyssa EL, Parsikia A, Jawa P, Dinh H-B, et al. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients. Exp Clin Transplant. 2013;11:222-8.
-
(2013)
Exp Clin Transplant
, vol.11
, pp. 222-228
-
-
Khanmoradi, K.1
Knorr, J.P.2
Feyssa, E.L.3
Parsikia, A.4
Jawa, P.5
Dinh, H.-B.6
-
68
-
-
84865657975
-
Thymoglobulin Antibody Immunosuppression in Living Donor Recipients Investigators. Antithymocyte globulin induction in living donor renal transplant recipients: Final report of the TAILOR registry
-
22850297 1:CAS:528:DC%2BC38Xht1GmtrbI
-
Gaber AO, Matas AJ, Henry ML, Brennan DC, Stevens RB, Kapur S, et al. Thymoglobulin Antibody Immunosuppression in Living Donor Recipients Investigators. Antithymocyte globulin induction in living donor renal transplant recipients: final report of the TAILOR registry. Transplantation. 2012;94:331-7.
-
(2012)
Transplantation
, vol.94
, pp. 331-337
-
-
Gaber, A.O.1
Matas, A.J.2
Henry, M.L.3
Brennan, D.C.4
Stevens, R.B.5
Kapur, S.6
-
69
-
-
84860465184
-
The effect of low and ultra-low dosages Thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients
-
22410573 1:CAS:528:DC%2BC38XmslyhtLY%3D
-
Kho MM, Bouvy AP, Cadogan M, Kraaijeveld R, Baan CC, Weimar W. The effect of low and ultra-low dosages Thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients. Transpl Immunol. 2012;26:186-90.
-
(2012)
Transpl Immunol
, vol.26
, pp. 186-190
-
-
Kho, M.M.1
Bouvy, A.P.2
Cadogan, M.3
Kraaijeveld, R.4
Baan, C.C.5
Weimar, W.6
-
70
-
-
0035865366
-
Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model
-
11233911
-
Préville X, Flacher M, LeMauff B, Beauchard S, Davelu P, Tiollier J, et al. Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model. Transplantation. 2001;71:460-8.
-
(2001)
Transplantation
, vol.71
, pp. 460-468
-
-
Préville, X.1
Flacher, M.2
Lemauff, B.3
Beauchard, S.4
Davelu, P.5
Tiollier, J.6
-
71
-
-
34547588360
-
Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation
-
17600336
-
Soliman T, Hetz H, Burghuber C, Gyöi G, Silberhumer G, Steininger R, et al. Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation. Liver Transplantation. 2007;13:1039-44.
-
(2007)
Liver Transplantation
, vol.13
, pp. 1039-1044
-
-
Soliman, T.1
Hetz, H.2
Burghuber, C.3
Gyöi, G.4
Silberhumer, G.5
Steininger, R.6
-
72
-
-
4143150743
-
Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids
-
15446319 1:CAS:528:DC%2BD2cXntVCqs7o%3D
-
Mourad G, Rostaing L, Legendre C, Garrigue V, Thervet E, Durand D. Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids. Transplantation. 2004;78:584-90.
-
(2004)
Transplantation
, vol.78
, pp. 584-590
-
-
Mourad, G.1
Rostaing, L.2
Legendre, C.3
Garrigue, V.4
Thervet, E.5
Durand, D.6
-
73
-
-
84866775392
-
Review article: Use of induction therapy in liver transplantation
-
Rostaing L, Saliba F, Calmus Y, Dharancy S, Boillot O. Review article: use of induction therapy in liver transplantation. Transplant Rev (Orlando). 2012;26:246-60.
-
(2012)
Transplant Rev (Orlando)
, vol.26
, pp. 246-260
-
-
Rostaing, L.1
Saliba, F.2
Calmus, Y.3
Dharancy, S.4
Boillot, O.5
-
74
-
-
34347232669
-
Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy
-
17613399
-
Mattei M, Redonnet M, Gandjbakhch I, Bandini AM, Billes A, Epailly E, et al. Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy. J Heart Lung Transplant. 2007;26:693-9.
-
(2007)
J Heart Lung Transplant
, vol.26
, pp. 693-699
-
-
Mattei, M.1
Redonnet, M.2
Gandjbakhch, I.3
Bandini, A.M.4
Billes, A.5
Epailly, E.6
-
75
-
-
33750628070
-
Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation
-
17097501
-
Flaman F, Zieroth S, Rao V, Ross H, Delgado DH. Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation. J Heart Lung Transplant. 2006;25:1358-62.
-
(2006)
J Heart Lung Transplant
, vol.25
, pp. 1358-1362
-
-
Flaman, F.1
Zieroth, S.2
Rao, V.3
Ross, H.4
Delgado, D.H.5
-
76
-
-
14644389386
-
Induction therapy after cardiac transplantation: A comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection
-
15737756
-
Carlsen J, Johansen M, Boesgaard S, Andersen CB, Arendrup H, Aldershvilet J, et al. Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection. J Heart Lung Transplant. 2005;24:296-302.
-
(2005)
J Heart Lung Transplant
, vol.24
, pp. 296-302
-
-
Carlsen, J.1
Johansen, M.2
Boesgaard, S.3
Andersen, C.B.4
Arendrup, H.5
Aldershvilet, J.6
-
77
-
-
84879024556
-
Induction therapy in heart transplantation: Where are we now?
-
23656308 1:CAS:528:DC%2BC3sXht1ChurjN
-
Aliabadi A, Grömmer M, Cochrane A, Salameh O, Zuckermann A. Induction therapy in heart transplantation: where are we now? Transpl Int. 2013;26:684-95.
-
(2013)
Transpl Int
, vol.26
, pp. 684-695
-
-
Aliabadi, A.1
Grömmer, M.2
Cochrane, A.3
Salameh, O.4
Zuckermann, A.5
-
78
-
-
52949108390
-
Induction therapy with thymoglobulin after heart transplantation: Impact of therapy duration on lymphocyte depletion and recovery, rejection, and cytomegalovirus infection rates
-
18926403
-
Goland S, Lawrence S, Czer C, De Robertis MA, Mirocha J, Zivari K, et al. Induction therapy with thymoglobulin after heart transplantation: impact of therapy duration on lymphocyte depletion and recovery, rejection, and cytomegalovirus infection rates. J Heart Lung Transplant. 2008;27:1115-21.
-
(2008)
J Heart Lung Transplant
, vol.27
, pp. 1115-1121
-
-
Goland, S.1
Lawrence, S.2
Czer, C.3
De Robertis, M.A.4
Mirocha, J.5
Zivari, K.6
-
79
-
-
0037181673
-
CD3 monitoring of antithymocyte globulin therapy in thoracic organ transplantation
-
11981432 1:CAS:528:DC%2BD38Xkt1Cqt7c%3D
-
Krasinskas AM, Kreisel D, Acker MA, Bavaria JE, Pochettino A, Kotloff RM, et al. CD3 monitoring of antithymocyte globulin therapy in thoracic organ transplantation. Transplantation. 2002;73:1339-41.
-
(2002)
Transplantation
, vol.73
, pp. 1339-1341
-
-
Krasinskas, A.M.1
Kreisel, D.2
Acker, M.A.3
Bavaria, J.E.4
Pochettino, A.5
Kotloff, R.M.6
-
80
-
-
22144434734
-
A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients
-
16003231 1:CAS:528:DC%2BD2MXlvVyltL4%3D
-
Hardinger KL, Bohl DL, Schnitzler MA, Lockwood M, Storch GA, Brennan DC. A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients. Transplantation. 2005;80:41-6.
-
(2005)
Transplantation
, vol.80
, pp. 41-46
-
-
Hardinger, K.L.1
Bohl, D.L.2
Schnitzler, M.A.3
Lockwood, M.4
Storch, G.A.5
Brennan, D.C.6
-
81
-
-
77953673127
-
Influence of polyclonal antithymocyte globulins on the expression of adhesion molecules of isolated human umbilical vein endothelial cells
-
1:CAS:528:DC%2BC3cXotVahu7g%3D
-
Walther S, Beiras-Fernandez A, Csapo C, Münzing S, Stief CG, Hammer C, et al. Influence of polyclonal antithymocyte globulins on the expression of adhesion molecules of isolated human umbilical vein endothelial cells. Transplantation Proc. 2010;42:1931-4.
-
(2010)
Transplantation Proc
, vol.42
, pp. 1931-1934
-
-
Walther, S.1
Beiras-Fernandez, A.2
Csapo, C.3
Münzing, S.4
Stief, C.G.5
Hammer, C.6
-
82
-
-
59649094303
-
Impact of polyclonal anti-thymocyte globulins on the expression of adhesion and inflammation molecules after ischemia-reperfusion injury
-
19041395 1:CAS:528:DC%2BD1MXhvF2qt7g%3D
-
Beiras-Fernandez A, Chappell D, Hammer C, Beiras A, Reichart B, Thein E. Impact of polyclonal anti-thymocyte globulins on the expression of adhesion and inflammation molecules after ischemia-reperfusion injury. Transpl Immunol. 2009;20:224-8.
-
(2009)
Transpl Immunol
, vol.20
, pp. 224-228
-
-
Beiras-Fernandez, A.1
Chappell, D.2
Hammer, C.3
Beiras, A.4
Reichart, B.5
Thein, E.6
-
83
-
-
5444230528
-
Polyclonal anti-thymocyte globulins influence apoptosis in reperfused tissues after ischemia in a non-human primate model
-
15338119 1:CAS:528:DC%2BD2cXot1aitbw%3D
-
Beiras-Fernandez A, Thein E, Chappell D, Gallego R, Fernandez-Roel D, Kemming G, et al. Polyclonal anti-thymocyte globulins influence apoptosis in reperfused tissues after ischemia in a non-human primate model. Transpl Int. 2004;17:453-7.
-
(2004)
Transpl Int
, vol.17
, pp. 453-457
-
-
Beiras-Fernandez, A.1
Thein, E.2
Chappell, D.3
Gallego, R.4
Fernandez-Roel, D.5
Kemming, G.6
-
84
-
-
79960097334
-
Thymoglobulin induction dosing strategies in a low-risk kidney transplant population: Three or four days?
-
21076531 2975077
-
Hardinger KL, Rasu RS, Skelton R, Miller BW, Brennan DC. Thymoglobulin induction dosing strategies in a low-risk kidney transplant population: three or four days? J Transplant. 2010;2010:957549.
-
(2010)
J Transplant
, vol.2010
, pp. 957549
-
-
Hardinger, K.L.1
Rasu, R.S.2
Skelton, R.3
Miller, B.W.4
Brennan, D.C.5
-
85
-
-
82655181497
-
Clinical and economic analysis of short-course versus standard-course antithymocyte globulin (rabbit) induction therapy in deceased-donor renal transplant recipients
-
22095818
-
Marfo K, Akalin E, Wang C, Lu A. Clinical and economic analysis of short-course versus standard-course antithymocyte globulin (rabbit) induction therapy in deceased-donor renal transplant recipients. Am J Health Syst Pharm. 2011;68:2276-82.
-
(2011)
Am J Health Syst Pharm
, vol.68
, pp. 2276-2282
-
-
Marfo, K.1
Akalin, E.2
Wang, C.3
Lu, A.4
-
86
-
-
21244477194
-
CD3 monitoring and thymoglobulin therapy in cardiac transplantation: Clinical outcomes and pharmacoeconomic implications
-
15686739 1:CAS:528:DC%2BD2MXitVemu74%3D
-
Uber WE, Uber LA, VanBakel AB, Crumbley AJ 3rd, Pereira NL, Ikonomidis JS, et al. CD3 monitoring and thymoglobulin therapy in cardiac transplantation: clinical outcomes and pharmacoeconomic implications. Transplant Proc. 2004;36:3245-9.
-
(2004)
Transplant Proc
, vol.36
, pp. 3245-3249
-
-
Uber, W.E.1
Uber, L.A.2
Vanbakel, A.B.3
Crumbley, A.J.4
Pereira, N.L.5
Ikonomidis, J.S.6
-
87
-
-
17844375977
-
Multivariate analysis of antibody induction therapy and their associated outcomes in deceased donor transplants
-
15848566 1:STN:280:DC%2BD2M3hsV2isA%3D%3D
-
Bunnapradist S, Takemoto SK. Multivariate analysis of antibody induction therapy and their associated outcomes in deceased donor transplants. Transplant Proc. 2005;37:889-91.
-
(2005)
Transplant Proc
, vol.37
, pp. 889-891
-
-
Bunnapradist, S.1
Takemoto, S.K.2
-
88
-
-
84892368518
-
Pretransplant identification of acute rejection risk following kidney transplantation
-
24118550 1:CAS:528:DC%2BC2cXnt1KktA%3D%3D
-
Lebranchu Y, Baan C, Biancone L, Legendre C, Morales JM, Naesens M, et al. Pretransplant identification of acute rejection risk following kidney transplantation. Transpl Int. 2014;27:129-38.
-
(2014)
Transpl Int
, vol.27
, pp. 129-138
-
-
Lebranchu, Y.1
Baan, C.2
Biancone, L.3
Legendre, C.4
Morales, J.M.5
Naesens, M.6
-
89
-
-
84870541810
-
Donor-specific antibodies adversely affect kidney allograft outcomes
-
23160511 3507372
-
Mohan S, Palanisamy A, Tsapepas D, Tanriover B, Crew RJ, Dube G, et al. Donor-specific antibodies adversely affect kidney allograft outcomes. J Am Soc Nephrol. 2012;23:2061-71.
-
(2012)
J Am Soc Nephrol
, vol.23
, pp. 2061-2071
-
-
Mohan, S.1
Palanisamy, A.2
Tsapepas, D.3
Tanriover, B.4
Crew, R.J.5
Dube, G.6
-
90
-
-
55949096202
-
Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation
-
18976305 1:STN:280:DC%2BD1cjmsVSjuw%3D%3D
-
Burns JM, Cornell LD, Perry DK, Pollinger HS, Gloor JM, Kremers WK, et al. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant. 2008;8:2684-94.
-
(2008)
Am J Transplant
, vol.8
, pp. 2684-2694
-
-
Burns, J.M.1
Cornell, L.D.2
Perry, D.K.3
Pollinger, H.S.4
Gloor, J.M.5
Kremers, W.K.6
-
91
-
-
67449100054
-
Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients
-
19470677 2689909
-
Noël C, Abramowicz D, Durand D, Mourad G, Lang P, Kessler M, et al. Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. J Am Soc Nephrol. 2009;20:1385-92.
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 1385-1392
-
-
Noël, C.1
Abramowicz, D.2
Durand, D.3
Mourad, G.4
Lang, P.5
Kessler, M.6
-
92
-
-
23944434883
-
A randomized trial of three renal transplant induction antibodies: Early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring
-
16123718 1:CAS:528:DC%2BD2MXpsVWrsbY%3D
-
Ciancio G, Burke GW, Gaynor JJ, Carreno MR, Cirocco RE, Mathew JM, et al. A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring. Transplantation. 2005;80:457-65.
-
(2005)
Transplantation
, vol.80
, pp. 457-465
-
-
Ciancio, G.1
Burke, G.W.2
Gaynor, J.J.3
Carreno, M.R.4
Cirocco, R.E.5
Mathew, J.M.6
-
93
-
-
44449112273
-
CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A
-
18199693 1:CAS:528:DC%2BD1cXmtlClsbY%3D
-
Abou-Ayache R, Büchler M, Lepogamp P, Westeel PF, Le Meur Y, Etienne I, et al. CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A. Nephrol Dial Transplant. 2008;23:2024-32.
-
(2008)
Nephrol Dial Transplant
, vol.23
, pp. 2024-2032
-
-
Abou-Ayache, R.1
Büchler, M.2
Lepogamp, P.3
Westeel, P.F.4
Le Meur, Y.5
Etienne, I.6
-
94
-
-
74949117314
-
TRIMS Study Investigators. A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin in living-donor kidney transplantation
-
19930408
-
Woodle ES, Peddi VR, Tomlanovich S, Mulgaonkar S, Kuo PC. TRIMS Study Investigators. A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin in living-donor kidney transplantation. Clin Transplant. 2009;24:73-83.
-
(2009)
Clin Transplant
, vol.24
, pp. 73-83
-
-
Woodle, E.S.1
Peddi, V.R.2
Tomlanovich, S.3
Mulgaonkar, S.4
Kuo, P.C.5
-
95
-
-
71749116888
-
Induction with and without antithymocyte globulin combined with cyclosporine/tacrolimus-based immunosuppression in renal transplantation: A meta-analysis of randomized controlled trials
-
19917365 1:CAS:528:DC%2BD1MXhsVajsbrJ
-
Tian JH, Wang X, Yang KH, Liu AP, Luo XF, Zhang J. Induction with and without antithymocyte globulin combined with cyclosporine/tacrolimus-based immunosuppression in renal transplantation: a meta-analysis of randomized controlled trials. Transplant Proc. 2009;41:3671-6.
-
(2009)
Transplant Proc
, vol.41
, pp. 3671-3676
-
-
Tian, J.H.1
Wang, X.2
Yang, K.H.3
Liu, A.P.4
Luo, X.F.5
Zhang, J.6
-
96
-
-
85027947747
-
Alemtuzumab induction therapy in kidney transplantation: A systematic review and meta-analysis
-
22660659 1:CAS:528:DC%2BC38XhtFOrsL3P
-
Morgan RD, O'Callaghan JM, Knight SR, Morris PJ. Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis. Transplantation. 2012;93:1179-88.
-
(2012)
Transplantation
, vol.93
, pp. 1179-1188
-
-
Morgan, R.D.1
O'Callaghan, J.M.2
Knight, S.R.3
Morris, P.J.4
-
97
-
-
79956189911
-
Alemtuzumab induction in renal transplantation
-
21591943 1:CAS:528:DC%2BC3MXmsFKht70%3D
-
Hanaway MJ, Woodle ES, Mulgaonkar S, Peddi VR, Kaufman DB, First MR, et al. Alemtuzumab induction in renal transplantation. N Engl J Med. 2011;364:1909-19.
-
(2011)
N Engl J Med
, vol.364
, pp. 1909-1919
-
-
Hanaway, M.J.1
Woodle, E.S.2
Mulgaonkar, S.3
Peddi, V.R.4
Kaufman, D.B.5
First, M.R.6
-
98
-
-
84873056180
-
Retreatment by antithymocyte globulin for second kidney transplantation:efficacy, tolerance and safety
-
Rodríguz-Reimundes E, Buron F, Chauvet C, Daoud S, Thaunat O, Brunet M, et al. Retreatment by antithymocyte globulin for second kidney transplantation:efficacy, tolerance and safety. Transpl Immunol. 2013;28:6-8.
-
(2013)
Transpl Immunol
, vol.28
, pp. 6-8
-
-
Rodríguz-Reimundes, E.1
Buron, F.2
Chauvet, C.3
Daoud, S.4
Thaunat, O.5
Brunet, M.6
-
99
-
-
17844405620
-
Thymoglobulin versus ATGAM induction therapy in pediatric kidney transplant recipients: A single-center report
-
15849550 1:CAS:528:DC%2BD2MXjsFagur0%3D
-
Khositseth S, Matas A, Cook ME, Gillingham KJ, Chavers BM. Thymoglobulin versus ATGAM induction therapy in pediatric kidney transplant recipients: a single-center report. Transplantation. 2005;79:958-63.
-
(2005)
Transplantation
, vol.79
, pp. 958-963
-
-
Khositseth, S.1
Matas, A.2
Cook, M.E.3
Gillingham, K.J.4
Chavers, B.M.5
-
100
-
-
33749572714
-
Five years' experience with thymoglobulin induction in a pediatric renal transplant population
-
17032426 1:STN:280:DC%2BD28ngtFyktg%3D%3D
-
Colleen Hastings M, Wyatt RJ, Lau KK, Jones DP, Powell SL, Hays DW, et al. Five years' experience with thymoglobulin induction in a pediatric renal transplant population. Pediatr Transplant. 2006;10:805-10.
-
(2006)
Pediatr Transplant
, vol.10
, pp. 805-810
-
-
Colleen Hastings, M.1
Wyatt, R.J.2
Lau, K.K.3
Jones, D.P.4
Powell, S.L.5
Hays, D.W.6
-
101
-
-
34748841992
-
Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression
-
17893604 1:CAS:528:DC%2BD2sXhtVOrtbvN
-
Schwartz JJ, Ishitani MB, Weckwerth J, Morgenstern B, Milliner D, Stegall MD. Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression. Transplantation. 2007;84:715-21.
-
(2007)
Transplantation
, vol.84
, pp. 715-721
-
-
Schwartz, J.J.1
Ishitani, M.B.2
Weckwerth, J.3
Morgenstern, B.4
Milliner, D.5
Stegall, M.D.6
-
102
-
-
0034965947
-
Comparison of polyclonal induction agents in pediatric renal transplantation
-
11422819 1:STN:280:DC%2BD3MzmtFaiug%3D%3D
-
Brophy PD, Thomas SE, McBryde KD, Bunchman TE. Comparison of polyclonal induction agents in pediatric renal transplantation. Pediatr Transplant. 2001;5:174-8.
-
(2001)
Pediatr Transplant
, vol.5
, pp. 174-178
-
-
Brophy, P.D.1
Thomas, S.E.2
McBryde, K.D.3
Bunchman, T.E.4
-
103
-
-
22144475434
-
Rabbit antithymocyte globulin as induction immunotherapy for pediatric deceased donor kidney transplantation
-
16006954
-
Kamel MH, Mohan P, Little DM, Awan A, Hickey DP. Rabbit antithymocyte globulin as induction immunotherapy for pediatric deceased donor kidney transplantation. J Urol. 2005;174:703-7.
-
(2005)
J Urol
, vol.174
, pp. 703-707
-
-
Kamel, M.H.1
Mohan, P.2
Little, D.M.3
Awan, A.4
Hickey, D.P.5
-
104
-
-
33744465024
-
Thymoglobulin induction is safe and effective in live-donor renal transplantation: A single center experience
-
16699456
-
Hardinger KL, Schnitzler MA, Koch MJ, Labile E, Stirnemann PM, Miller B, et al. Thymoglobulin induction is safe and effective in live-donor renal transplantation: a single center experience. Transplantation. 2006;81:1285-9.
-
(2006)
Transplantation
, vol.81
, pp. 1285-1289
-
-
Hardinger, K.L.1
Schnitzler, M.A.2
Koch, M.J.3
Labile, E.4
Stirnemann, P.M.5
Miller, B.6
-
105
-
-
25144498720
-
Immunosuppression with antithymocyte globulin in renal transplantation: Better long-term graft survival
-
16182802 1:CAS:528:DC%2BD2MXhtVegtLrI
-
Martins L, Fonseca I, Almeida M, Henriques AC, Dias L, Sarmento AM, et al. Immunosuppression with antithymocyte globulin in renal transplantation: better long-term graft survival. Transplant Proc. 2005;37:2755-8.
-
(2005)
Transplant Proc
, vol.37
, pp. 2755-2758
-
-
Martins, L.1
Fonseca, I.2
Almeida, M.3
Henriques, A.C.4
Dias, L.5
Sarmento, A.M.6
-
106
-
-
0027266968
-
Induction therapy with antithymocyte globulin reduces the incidence of allograft rejection and improves graft survival in cadaver renal transplantation
-
8516886 1:STN:280:DyaK3s3ps12gtg%3D%3D
-
Abouna GM, Kumar MS, Stephan R, Prior JE, Lyons P, Bulova SI, et al. Induction therapy with antithymocyte globulin reduces the incidence of allograft rejection and improves graft survival in cadaver renal transplantation. Transplant Proc. 1993;25:2241-2.
-
(1993)
Transplant Proc
, vol.25
, pp. 2241-2242
-
-
Abouna, G.M.1
Kumar, M.S.2
Stephan, R.3
Prior, J.E.4
Lyons, P.5
Bulova, S.I.6
-
107
-
-
33744457937
-
Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients
-
16699447 1:CAS:528:DC%2BD28XksFKgtLg%3D
-
Opelz G, Naujokat C, Daniel V, Terness P, Döhler B. Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients. Transplantation. 2006;81:1227-33.
-
(2006)
Transplantation
, vol.81
, pp. 1227-1233
-
-
Opelz, G.1
Naujokat, C.2
Daniel, V.3
Terness, P.4
Döhler, B.5
-
108
-
-
67649610609
-
Early outcomes of thymoglobulin and basiliximab induction in kidney transplantation: Application of statistical approaches to reduce bias in observational comparisons
-
19461489 1:CAS:528:DC%2BD1MXmtFKhs7Y%3D 2833330
-
Willoughby LM, Schnitzler MA, Brennan DC, Pinsky BW, Dzebisashvili N, Buchanan PM, et al. Early outcomes of thymoglobulin and basiliximab induction in kidney transplantation: application of statistical approaches to reduce bias in observational comparisons. Transplantation. 2009;87:1520-9.
-
(2009)
Transplantation
, vol.87
, pp. 1520-1529
-
-
Willoughby, L.M.1
Schnitzler, M.A.2
Brennan, D.C.3
Pinsky, B.W.4
Dzebisashvili, N.5
Buchanan, P.M.6
-
109
-
-
84857655507
-
Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients
-
22306574 1:CAS:528:DC%2BC38XivVOksLY%3D
-
Kuo HT, Huang E, Emami S, Pham PT, Wilkinson AH, Danovitch GM, et al. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients. Transplantation. 2012;93:493-502.
-
(2012)
Transplantation
, vol.93
, pp. 493-502
-
-
Kuo, H.T.1
Huang, E.2
Emami, S.3
Pham, P.T.4
Wilkinson, A.H.5
Danovitch, G.M.6
-
110
-
-
84910148473
-
Comparative effectiveness of rabbit anti-thymocyte globulin vs. interleukin-2 receptor blockers in deceased donor kidney transplants with delayed graft function
-
Abstract 173
-
Oweis A, Zaltzman J, Kim J. Comparative effectiveness of rabbit anti-thymocyte globulin vs. interleukin-2 receptor blockers in deceased donor kidney transplants with delayed graft function. Am J Transplant 2013;13(Suppl 5):Abstract 173.
-
(2013)
Am J Transplant
, vol.13
, Issue.5
-
-
Oweis, A.1
Zaltzman, J.2
Kim, J.3
-
111
-
-
22244464550
-
Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury
-
16008596
-
Bogetti D, Sankary HN, Jarzembowski TM, Manzelli A, Knight PS, Thielke J, et al. Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury. Clin Transplant. 2005;19:507-11.
-
(2005)
Clin Transplant
, vol.19
, pp. 507-511
-
-
Bogetti, D.1
Sankary, H.N.2
Jarzembowski, T.M.3
Manzelli, A.4
Knight, P.S.5
Thielke, J.6
-
112
-
-
84988850841
-
Timing of rabbit antithymocyte globulin induction therapy in kidney transplantation: An observational cohort study
-
24387192 3882095
-
Harrison JJ, Hamandi B, Li Y, Famure O, Kim SJ. Timing of rabbit antithymocyte globulin induction therapy in kidney transplantation: an observational cohort study. Transplant Res. 2014;3:1.
-
(2014)
Transplant Res
, vol.3
, pp. 1
-
-
Harrison, J.J.1
Hamandi, B.2
Li, Y.3
Famure, O.4
Kim, S.J.5
-
113
-
-
42449083822
-
Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation
-
17890265
-
Mehrabi A, Mood ZhA, Sadeghi M, Schmied BM, Müller SA, Welsch T, et al. Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation. Nephrol Dial Transplant. 2007;22(Suppl 8):viii54-60.
-
(2007)
Nephrol Dial Transplant
, vol.22
, Issue.8
, pp. 54-viii60
-
-
Mehrabi, A.1
Mood, Z.2
Sadeghi, M.3
Schmied, B.M.4
Müller, S.A.5
Welsch, T.6
-
114
-
-
84926179759
-
The DGFS: A useful scoring system for the prediction and management of delayed graft function following kidney transplantation from cadaveric donors
-
Chapal M, Le Borgne F, Legendre C, Kreis H, Mourad G, Garrigue V, et al. The DGFS: a useful scoring system for the prediction and management of delayed graft function following kidney transplantation from cadaveric donors. Kidney Int 2014. doi: 10.1038/ki.2014.188.
-
(2014)
Kidney Int
-
-
Chapal, M.1
Le Borgne, F.2
Legendre, C.3
Kreis, H.4
Mourad, G.5
Garrigue, V.6
-
115
-
-
0034010991
-
Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study Group
-
10715452 1:CAS:528:DC%2BD3cXhslars7s%3D
-
Lebranchu Y, Aubert P, Bayle F, Bedrossian J, Berthoux F, Bourbigot B, et al. Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study Group. Transplant Proc. 2000;32:396-7.
-
(2000)
Transplant Proc
, vol.32
, pp. 396-397
-
-
Lebranchu, Y.1
Aubert, P.2
Bayle, F.3
Bedrossian, J.4
Berthoux, F.5
Bourbigot, B.6
-
116
-
-
68249117074
-
Pediatric kidney transplantation using a novel protocol of rapid (6-day) discontinuation of prednisone: 2-year results
-
19623020 1:CAS:528:DC%2BD1MXovVSgtbY%3D 2746733
-
Chavers BM, Chang YC, Gillingham KJ, Matas A. Pediatric kidney transplantation using a novel protocol of rapid (6-day) discontinuation of prednisone: 2-year results. Transplantation. 2009;88:237-41.
-
(2009)
Transplantation
, vol.88
, pp. 237-241
-
-
Chavers, B.M.1
Chang, Y.C.2
Gillingham, K.J.3
Matas, A.4
-
117
-
-
78650837441
-
Efficacy and safety of thymoglobulin induction as an alternative approach for steroid-free maintenance immunosuppression in pediatric renal transplantation
-
20935596 1:CAS:528:DC%2BC3cXhsFGrtrfN
-
Li L, Chaudhuri A, Chen A, Zhao X, Bezchinsky M, Concepcion W, et al. Efficacy and safety of thymoglobulin induction as an alternative approach for steroid-free maintenance immunosuppression in pediatric renal transplantation. Transplantation. 2010;90:1516-20.
-
(2010)
Transplantation
, vol.90
, pp. 1516-1520
-
-
Li, L.1
Chaudhuri, A.2
Chen, A.3
Zhao, X.4
Bezchinsky, M.5
Concepcion, W.6
-
118
-
-
79957606092
-
Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawal
-
21923440 1:CAS:528:DC%2BC3MXot1Gitbg%3D
-
Martin ST, Roberts KL, Malek SK, Tullius SG, Vadivel N, De Serres S, et al. Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawal. Pharmacotherapy. 2011;31:566-73.
-
(2011)
Pharmacotherapy
, vol.31
, pp. 566-573
-
-
Martin, S.T.1
Roberts, K.L.2
Malek, S.K.3
Tullius, S.G.4
Vadivel, N.5
De Serres, S.6
-
119
-
-
0037164337
-
Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy
-
12457792 1:CAS:528:DC%2BD38XovFegt7s%3D
-
Swanson SJ, Hale DA, Mannon RB, Kleiner DE, Cendales LC, Chamberlain CE, et al. Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy. Lancet. 2002;360:1662-4.
-
(2002)
Lancet
, vol.360
, pp. 1662-1664
-
-
Swanson, S.J.1
Hale, D.A.2
Mannon, R.B.3
Kleiner, D.E.4
Cendales, L.C.5
Chamberlain, C.E.6
-
120
-
-
0345098542
-
Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: Results after 5 years
-
12879230
-
Grinyó JM, Gil-Vernet S, Cruzado JM, Caldés A, Riera L, Serón D, et al. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years. Transpl Int. 2003;16:820-7.
-
(2003)
Transpl Int
, vol.16
, pp. 820-827
-
-
Grinyó, J.M.1
Gil-Vernet, S.2
Cruzado, J.M.3
Caldés, A.4
Riera, L.5
Serón, D.6
-
121
-
-
84863189669
-
Five-year results of a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation: The SPIESSER study
-
22486815 1:CAS:528:DC%2BC38Xht1ygs77E
-
Lebranchu Y, Snanoudj R, Toupance O, Weestel PF, Hurault de Ligny B, Buchler M, et al. Five-year results of a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation: the SPIESSER study. Am J Transplant. 2012;12:1801-10.
-
(2012)
Am J Transplant
, vol.12
, pp. 1801-1810
-
-
Lebranchu, Y.1
Snanoudj, R.2
Toupance, O.3
Weestel, P.F.4
Hurault De Ligny, B.5
Buchler, M.6
-
122
-
-
79951473731
-
Calcineurin inhibitor-free monotherapy in human leukocyte antigen-identical live donor renal transplantation
-
21344733 1:CAS:528:DC%2BC3MXhtFCit70%3D
-
Venot M, Abboud I, Duboust A, Michel C, Suberbielle C, Vérine J, et al. Calcineurin inhibitor-free monotherapy in human leukocyte antigen-identical live donor renal transplantation. Transplantation. 2011;91:330-3.
-
(2011)
Transplantation
, vol.91
, pp. 330-333
-
-
Venot, M.1
Abboud, I.2
Duboust, A.3
Michel, C.4
Suberbielle, C.5
Vérine, J.6
-
123
-
-
37349034394
-
ELITE-Symphony Study. Reduced exposure to calcineurin inhibitors in renal transplantation
-
Ekberg H, Tedesco-Silva H, Demirbas A, Vítko S, Nashan B, Gürkan A, et al; ELITE-Symphony Study. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med. 2007;357:2562-75.
-
(2007)
N Engl J Med
, vol.357
, pp. 2562-2575
-
-
Ekberg H, T.1
-
124
-
-
79961032806
-
The ORION Study: Comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients
-
21668635 1:CAS:528:DC%2BC3MXhtFOqtbbN
-
Flechner SM, Glyda M, Cockfield S, Grinyó J, Legendre Ch, Russ G, et al. The ORION Study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients. Am J Transplant. 2011;11:1633-44.
-
(2011)
Am J Transplant
, vol.11
, pp. 1633-1644
-
-
Flechner, S.M.1
Glyda, M.2
Cockfield, S.3
Grinyó, J.4
Legendre, C.5
Russ, G.6
-
125
-
-
84910146805
-
Thymoglobulin plus basiliximab versus basiliximab induction in deceased donor kidney transplant recipients treated with tacrolimus and MMF: 1-year results of a prospective clinical trial
-
Favi E, Spagnoletti G, Silvestrini N, Salerno MP, Pedroso JA, Romagnoli J, et al. Thymoglobulin plus basiliximab versus basiliximab induction in deceased donor kidney transplant recipients treated with tacrolimus and MMF: 1-year results of a prospective clinical trial. Transpl Int. 2013;26 Suppl s2:83.
-
(2013)
Transpl Int
, vol.26
-
-
Favi, E.1
Spagnoletti, G.2
Silvestrini, N.3
Salerno, M.P.4
Pedroso, J.A.5
Romagnoli, J.6
-
126
-
-
78650887509
-
Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients
-
21114656 1:STN:280:DC%2BC3M%2Fot1Kntw%3D%3D
-
Ferguson R, Grinyó J, Vincenti F, Kaufman DB, Woodle ES, Marder BA, et al. Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients. Am J Transplant. 2011;11:66-76.
-
(2011)
Am J Transplant
, vol.11
, pp. 66-76
-
-
Ferguson, R.1
Grinyó, J.2
Vincenti, F.3
Kaufman, D.B.4
Woodle, E.S.5
Marder, B.A.6
-
128
-
-
84883411990
-
In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development
-
23913968 1:CAS:528:DC%2BC3sXhtlSgtL3P
-
Todeschini M, Cortinovis M, Perico N, Poli F, Innocente A, Cavinato RA, et al. In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development. J Immunol. 2013;191:2818-28.
-
(2013)
J Immunol
, vol.191
, pp. 2818-2828
-
-
Todeschini, M.1
Cortinovis, M.2
Perico, N.3
Poli, F.4
Innocente, A.5
Cavinato, R.A.6
-
129
-
-
59649100274
-
Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin
-
19155977 1:CAS:528:DC%2BD1MXotVanug%3D%3D
-
Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, et al. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin. Transplantation. 2009;87:227-32.
-
(2009)
Transplantation
, vol.87
, pp. 227-232
-
-
Mai, M.L.1
Ahsan, N.2
Wadei, H.M.3
Genco, P.V.4
Geiger, X.J.5
Willingham, D.L.6
-
130
-
-
84892973955
-
Crossmatch-positive liver transplantation in patients receiving thymoglobulin-rituximab induction
-
24030603 1:CAS:528:DC%2BC2cXisVektQ%3D%3D
-
Kubal CA, Mangus RS, Saxena R, Lobashevsky A, Higgins N, Agarwal A, et al. Crossmatch-positive liver transplantation in patients receiving thymoglobulin-rituximab induction. Transplantation. 2014;97:56-63.
-
(2014)
Transplantation.
, vol.97
, pp. 56-63
-
-
Kubal, C.A.1
Mangus, R.S.2
Saxena, R.3
Lobashevsky, A.4
Higgins, N.5
Agarwal, A.6
-
131
-
-
79955629290
-
Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodes
-
21403588 1:CAS:528:DC%2BC3MXlsFGls70%3D
-
Cooper JE, Gralla J, Cagle L, Goldberg R, Chan L, Wiseman AC. Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodes. Transplantation. 2011;91:1103-9.
-
(2011)
Transplantation
, vol.91
, pp. 1103-1109
-
-
Cooper, J.E.1
Gralla, J.2
Cagle, L.3
Goldberg, R.4
Chan, L.5
Wiseman, A.C.6
-
132
-
-
84879149882
-
Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation
-
Huang Y, Ramon D, Luan FL, Sung R, Samaniego M. Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation. Clin Transplant. 2012;247-56.
-
(2012)
Clin Transplant
, pp. 247-256
-
-
Huang, Y.1
Ramon, D.2
Luan, F.L.3
Sung, R.4
Samaniego, M.5
-
133
-
-
84884505267
-
Complement-binding anti-HLA antibodies and kidney-allograft survival
-
24066742 1:CAS:528:DC%2BC3sXhsFGktLjK
-
Loupy AD, Lefaucheur C, Vernerey D, Prugger C, Duong van Huyen JP, Mooney N, et al. Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med. 2013;369:1215-26.
-
(2013)
N Engl J Med.
, vol.369
, pp. 1215-1226
-
-
Loupy, A.D.1
Lefaucheur, C.2
Vernerey, D.3
Prugger, C.4
Duong Van Huyen, J.P.5
Mooney, N.6
-
134
-
-
78650842081
-
Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: An analysis of United Network for Organ Sharing registry data
-
21057388 1:CAS:528:DC%2BC3cXhsFGrtrbF
-
Cai J, Terasaki PI. Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data. Transplantation. 2010;90:1511-5.
-
(2010)
Transplantation
, vol.90
, pp. 1511-1515
-
-
Cai, J.1
Terasaki, P.I.2
-
135
-
-
76949101979
-
The influence of induction therapy on graft and patient survival in patients with and without hepatitis C after liver transplantation
-
19958339 1:STN:280:DC%2BC3c3osVektw%3D%3D
-
Moonka DK, Kim D, Kapke A, Brown KA, Yoshida A. The influence of induction therapy on graft and patient survival in patients with and without hepatitis C after liver transplantation. Am J Transplant. 2010;10:590-601.
-
(2010)
Am J Transplant
, vol.10
, pp. 590-601
-
-
Moonka, D.K.1
Kim, D.2
Kapke, A.3
Brown, K.A.4
Yoshida, A.5
-
136
-
-
84863884404
-
Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up
-
22237953
-
Mangus R, Fridell AJ, Vianna RM, Kwo PY, Chen J, Tector AJ. Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up. Liver Transpl. 2012;18:786-95.
-
(2012)
Liver Transpl
, vol.18
, pp. 786-795
-
-
Mangus, R.1
Fridell, A.J.2
Vianna, R.M.3
Kwo, P.Y.4
Chen, J.5
Tector, A.J.6
-
137
-
-
72949089451
-
Thymoglobulin induction in liver transplant recipients with a tacrolimus, mycophenolate mofetil, and steroid immunosuppressive regimen: A five-year randomized prospective study
-
19877264
-
Boillot O, Seket B, Dumortier J, Pittau G, Boucaud C, Bouffard Y, et al. Thymoglobulin induction in liver transplant recipients with a tacrolimus, mycophenolate mofetil, and steroid immunosuppressive regimen: a five-year randomized prospective study. Liver Transpl. 2009;15:1426-34.
-
(2009)
Liver Transpl
, vol.15
, pp. 1426-1434
-
-
Boillot, O.1
Seket, B.2
Dumortier, J.3
Pittau, G.4
Boucaud, C.5
Bouffard, Y.6
-
138
-
-
24044471631
-
Antithymocyte globulin induction therapy in hepatitis C-positive liver transplant recipients
-
16137581
-
Horton PJ, Tchervenkov J, Barkun JS, Rochon C, Chaudhury PK, Znajda TL, et al. Antithymocyte globulin induction therapy in hepatitis C-positive liver transplant recipients. J Gastrointest Surg. 2005;9:896-902.
-
(2005)
J Gastrointest Surg
, vol.9
, pp. 896-902
-
-
Horton, P.J.1
Tchervenkov, J.2
Barkun, J.S.3
Rochon, C.4
Chaudhury, P.K.5
Znajda, T.L.6
-
139
-
-
0030671476
-
Use of thymoglobulin induction therapy in the prevention of acute graft rejection episodes following liver transplantation
-
9366919 1:STN:280:DyaK1c%2FjtlOitg%3D%3D
-
Tchervenkov J, Flemming C, Guttmann RD, Des Gachons G. Use of thymoglobulin induction therapy in the prevention of acute graft rejection episodes following liver transplantation. Transplant Proc. 1997;29(Suppl 7A):13S-5S.
-
(1997)
Transplant Proc
, vol.29
, pp. 13S-15S
-
-
Tchervenkov, J.1
Flemming, C.2
Guttmann, R.D.3
Des Gachons, G.4
-
140
-
-
84910119261
-
Antithymocyte globulin induction is associated with improved graft survival and reduced ischemic cholangiopathy after DCD liver transplantation as compared to basiliximab [abstract no. 265]
-
Halldorson J, Bakthavatsalam B, Dick A, Rayhill S, Perkins J, Reyes J. Antithymocyte globulin induction is associated with improved graft survival and reduced ischemic cholangiopathy after DCD liver transplantation as compared to basiliximab [abstract no. 265]. Am J Transplant. 2013;13 Suppl 5.
-
(2013)
Am J Transplant
, vol.13
, Issue.5
-
-
Halldorson, J.1
Bakthavatsalam, B.2
Dick, A.3
Rayhill, S.4
Perkins, J.5
Reyes, J.6
-
141
-
-
12144286031
-
Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients
-
15004768
-
Tector AJ, Fridell JA, Mangus RS, Shah A, Milgrom M, Kwo P, et al. Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients. Liver Transpl. 2004;10:404-7.
-
(2004)
Liver Transpl
, vol.10
, pp. 404-407
-
-
Tector, A.J.1
Fridell, J.A.2
Mangus, R.S.3
Shah, A.4
Milgrom, M.5
Kwo, P.6
-
142
-
-
29544443396
-
Initial immunosuppression in liver transplant recipients with impaired renal function
-
16386581 1:CAS:528:DC%2BD28XksVej
-
Varo E, López A, Rivero C. Initial immunosuppression in liver transplant recipients with impaired renal function. Transplant Proc. 2005;37:3909-12.
-
(2005)
Transplant Proc
, vol.37
, pp. 3909-3912
-
-
Varo, E.1
López, A.2
Rivero, C.3
-
143
-
-
0030864642
-
Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation
-
9317061 1:STN:280:DyaK2svmtFersg%3D%3D
-
Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, et al. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol. 1997;92:1453-7.
-
(1997)
Am J Gastroenterol
, vol.92
, pp. 1453-1457
-
-
Rosen, H.R.1
Shackleton, C.R.2
Higa, L.3
Gralnek, I.M.4
Farmer, D.A.5
McDiarmid, S.V.6
-
144
-
-
79959814160
-
Outcome of induction immunosuppression for liver transplantation comparing anti-thymocyte globulin, daclizumab, and corticosteroid
-
21429047 1:CAS:528:DC%2BC3MXpvVWqu7k%3D
-
Uemura T, Schaefer E, Hollenbeak CS, Khan A, Kadry Z. Outcome of induction immunosuppression for liver transplantation comparing anti-thymocyte globulin, daclizumab, and corticosteroid. Transpl Int. 2011;24:640-50.
-
(2011)
Transpl Int
, vol.24
, pp. 640-650
-
-
Uemura, T.1
Schaefer, E.2
Hollenbeak, C.S.3
Khan, A.4
Kadry, Z.5
-
145
-
-
52049116745
-
Efficacy of interferon based antiviral therapy for recurrent hepatitis C in patients who received steroid free immunosuppression for liver transplantation
-
18698245 1:CAS:528:DC%2BD1cXpvFynt7Y%3D
-
Nair S, Lipscomb J, Eason J. Efficacy of interferon based antiviral therapy for recurrent hepatitis C in patients who received steroid free immunosuppression for liver transplantation. Transplantation. 2008;86:418-22.
-
(2008)
Transplantation
, vol.86
, pp. 418-422
-
-
Nair, S.1
Lipscomb, J.2
Eason, J.3
-
146
-
-
19944417233
-
Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C
-
15621141 1:CAS:528:DC%2BD2cXhtFGhtLfI
-
Kamar N, Ribes D, Sandres-Saune K, Suc B, Barange K, Cointault O, et al. Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C. Transplant Proc. 2004;36:2757-61.
-
(2004)
Transplant Proc
, vol.36
, pp. 2757-2761
-
-
Kamar, N.1
Ribes, D.2
Sandres-Saune, K.3
Suc, B.4
Barange, K.5
Cointault, O.6
-
147
-
-
38549103672
-
Thymoglobulin induction and steroid avoidance in cardiac transplantation: Results of a prospective, randomized, controlled study
-
18251036
-
Yamani MH, Taylor DO, Czerr J, Haire C, Kring R, Zhou L, et al. Thymoglobulin induction and steroid avoidance in cardiac transplantation: results of a prospective, randomized, controlled study. Clin Transplant. 2008;22:76-81.
-
(2008)
Clin Transplant
, vol.22
, pp. 76-81
-
-
Yamani, M.H.1
Taylor, D.O.2
Czerr, J.3
Haire, C.4
Kring, R.5
Zhou, L.6
-
148
-
-
33847405816
-
Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: A non-inferiority trial
-
Carrier M, Leblanc MH, Perrault LP, White M, Doyle D, Beaudoin D, et al. Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial. Heart Lung Transplant. 2007;26:258-63.
-
(2007)
Heart Lung Transplant
, vol.26
, pp. 258-263
-
-
Carrier, M.1
Leblanc, M.H.2
Perrault, L.P.3
White, M.4
Doyle, D.5
Beaudoin, D.6
-
149
-
-
53149128006
-
Induction immunosuppression with basiliximab in heart transplantation
-
18929820 1:CAS:528:DC%2BD1cXht1eitrvK
-
Chou NK, Wang SS, Chen YS, Yu HY, Chi NH, Wang CH, et al. Induction immunosuppression with basiliximab in heart transplantation. Transplant Proc. 2008;40:2623-5.
-
(2008)
Transplant Proc
, vol.40
, pp. 2623-2625
-
-
Chou, N.K.1
Wang, S.S.2
Chen, Y.S.3
Yu, H.Y.4
Chi, N.H.5
Wang, C.H.6
-
150
-
-
84876930437
-
Everolimus versus mycophenolate mofetil in heart transplantation: A randomized, multicenter trial
-
23433101 1:CAS:528:DC%2BC3sXovFKisLg%3D
-
Eisen HJ, Kobashigawa J, Starling RC, Pauly DR, Kfoury A, Ross H, et al. Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial. Am J Transplant. 2013;13:1203-16.
-
(2013)
Am J Transplant.
, vol.13
, pp. 1203-1216
-
-
Eisen, H.J.1
Kobashigawa, J.2
Starling, R.C.3
Pauly, D.R.4
Kfoury, A.5
Ross, H.6
-
151
-
-
84910136448
-
The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients
-
Baran DA, Carboni M, Dengler T, Feldman D, Frigerio M, Kfoury A, et al. The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients. Task Force 2: immunosuppression and rejection. ISHLT; 2010: pp. 1-41.
-
(2010)
Task Force 2: Immunosuppression and Rejection. ISHLT
, pp. 1-41
-
-
Baran, D.A.1
Carboni, M.2
Dengler, T.3
Feldman, D.4
Frigerio, M.5
Kfoury, A.6
-
152
-
-
13444311969
-
Use of basiliximab and cyclosporine in heart transplant patients with pre-operative renal dysfunction
-
15701432
-
Delgado DH, Miriuka SG, Cusimano RJ, Feindel C, Rao V, Ross HJ. Use of basiliximab and cyclosporine in heart transplant patients with pre-operative renal dysfunction. J Heart Lung Transplant. 2005;24:166-9.
-
(2005)
J Heart Lung Transplant
, vol.24
, pp. 166-169
-
-
Delgado, D.H.1
Miriuka, S.G.2
Cusimano, R.J.3
Feindel, C.4
Rao, V.5
Ross, H.J.6
-
153
-
-
4544325560
-
Antithymocyte globulin induction allows a prolonged delay in the initiation of cyclosporine in heart transplant patients with postoperative renal dysfunction
-
15371689 1:CAS:528:DC%2BD2cXnsFGqs7c%3D
-
Cantarovich M, Giannetti N, Barkun J, Cecere R. Antithymocyte globulin induction allows a prolonged delay in the initiation of cyclosporine in heart transplant patients with postoperative renal dysfunction. Transplantation. 2004;78:779-81.
-
(2004)
Transplantation
, vol.78
, pp. 779-781
-
-
Cantarovich, M.1
Giannetti, N.2
Barkun, J.3
Cecere, R.4
-
154
-
-
84910141031
-
Clinical outcome in heart transplant recipients with chronic kidney disease receiving Thymoglobulin for induction therapy
-
Congress
-
Fuchs U, Zittermann A, Amini A, Ensminger SM, Gummert JF, Schulz U. Clinical outcome in heart transplant recipients with chronic kidney disease receiving Thymoglobulin for induction therapy. German Transplant Society (DTG) Congress 2013.
-
(2013)
German Transplant Society (DTG)
-
-
Fuchs, U.1
Zittermann, A.2
Amini, A.3
Ensminger, S.M.4
Gummert, J.F.5
Schulz, U.6
-
155
-
-
77950519096
-
Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients
-
20061164
-
Singh TP, Faber C, Blume ED, Worley S, Almond CS, Smoot LB, et al. Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients. J Heart Lung Transplant. 2010;29:517-22.
-
(2010)
J Heart Lung Transplant
, vol.29
, pp. 517-522
-
-
Singh, T.P.1
Faber, C.2
Blume, E.D.3
Worley, S.4
Almond, C.S.5
Smoot, L.B.6
-
156
-
-
42649092878
-
Cardiac allograft vasculopathy: Recent developments
-
18427143
-
Schmauss D, Weis M. Cardiac allograft vasculopathy: recent developments. Circulation. 2008;117:2131-41.
-
(2008)
Circulation
, vol.117
, pp. 2131-2141
-
-
Schmauss, D.1
Weis, M.2
-
157
-
-
0035993796
-
Low incidence of graft arteriosclerosis after cardiac transplantation: Risk factor analysis for patients with induction therapy
-
12176608 1:STN:280:DC%2BD38vit1yltg%3D%3D
-
Zuckermann A, Ploner M, Czerny M, Keziban U, Birsan T, Laufer G, et al. Low incidence of graft arteriosclerosis after cardiac transplantation: risk factor analysis for patients with induction therapy. Transplant Proc. 2002;34:1869-71.
-
(2002)
Transplant Proc
, vol.34
, pp. 1869-1871
-
-
Zuckermann, A.1
Ploner, M.2
Czerny, M.3
Keziban, U.4
Birsan, T.5
Laufer, G.6
-
158
-
-
33748162571
-
Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation
-
16962480
-
Bonaros N, Dunkler D, Kocher A, Imhof M, Grimm M, Zuckermann A, et al. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation. J Heart Lung Transplant. 2006;25:1154-63.
-
(2006)
J Heart Lung Transplant
, vol.25
, pp. 1154-1163
-
-
Bonaros, N.1
Dunkler, D.2
Kocher, A.3
Imhof, M.4
Grimm, M.5
Zuckermann, A.6
-
159
-
-
0032738939
-
A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation
-
10612381 1:STN:280:DC%2BD3c%2FnslKhug%3D%3D
-
Carrier M, White M, Perrault LP, Pelletier GB, Pellerin M, Robitaille D, et al. A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation. J Heart Lung Transplant. 1999;18:1218-23.
-
(1999)
J Heart Lung Transplant
, vol.18
, pp. 1218-1223
-
-
Carrier, M.1
White, M.2
Perrault, L.P.3
Pelletier, G.B.4
Pellerin, M.5
Robitaille, D.6
-
160
-
-
78649465610
-
Antithymocyte globulin induction therapy in heart transplantation: Prospective randomized study of high vs standard dosage
-
21094838 1:CAS:528:DC%2BC3cXhsVGnt7fO
-
Faggian G, Forni A, Milano AD, Chiominto B, Walpoth BH, Scarabelli T, et al. Antithymocyte globulin induction therapy in heart transplantation: prospective randomized study of high vs standard dosage. Transplant Proc. 2010;42:3679-87.
-
(2010)
Transplant Proc
, vol.42
, pp. 3679-3687
-
-
Faggian, G.1
Forni, A.2
Milano, A.D.3
Chiominto, B.4
Walpoth, B.H.5
Scarabelli, T.6
-
161
-
-
44049104354
-
Delayed onset of cardiac allograft vasculopathy by induction therapy using anti-thymocyte globulin
-
18503958 1:CAS:528:DC%2BD1MXpt1WhsA%3D%3D
-
Zhang R, Haverich A, Strüber M, Simon A, Bara C. Delayed onset of cardiac allograft vasculopathy by induction therapy using anti-thymocyte globulin. J Heart Lung Transplant. 2008;27:603-9.
-
(2008)
J Heart Lung Transplant
, vol.27
, pp. 603-609
-
-
Zhang, R.1
Haverich, A.2
Strüber, M.3
Simon, A.4
Bara, C.5
-
162
-
-
84879023426
-
Induction therapy in lung transplantation
-
1:CAS:528:DC%2BC3sXht1ChurjP
-
Sweet SC. Induction therapy in lung transplantation. Transplant Int. 2013;26:696-703.
-
(2013)
Transplant Int.
, vol.26
, pp. 696-703
-
-
Sweet, S.C.1
-
163
-
-
79960555865
-
A review of bronchiolitis obliterans syndrome and therapeutic strategies
-
21767391 3162889
-
Hayes D Jr. A review of bronchiolitis obliterans syndrome and therapeutic strategies. J Cardiothorac Surg. 2011;6:92.
-
(2011)
J Cardiothorac Surg
, vol.6
, pp. 92
-
-
Hayes, D.1
-
164
-
-
80051491362
-
Bronchiolitis obliterans syndrome: The final frontier for lung transplantation
-
21813529
-
Todd JL, Palmer SM. Bronchiolitis obliterans syndrome: the final frontier for lung transplantation. Chest. 2011;140:502-8.
-
(2011)
Chest
, vol.140
, pp. 502-508
-
-
Todd, J.L.1
Palmer, S.M.2
-
165
-
-
79953908284
-
Update on infectious complications following lung transplantation
-
21326099 1:CAS:528:DC%2BC3MXjslKrtb0%3D
-
Lease ED, Zaas DW. Update on infectious complications following lung transplantation. Curr Opin Pulm Med. 2011;17:206-9.
-
(2011)
Curr Opin Pulm Med
, vol.17
, pp. 206-209
-
-
Lease, E.D.1
Zaas, D.W.2
-
166
-
-
84866127151
-
The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012
-
22975097
-
Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant. 2012;31:1073-86.
-
(2012)
J Heart Lung Transplant
, vol.31
, pp. 1073-1086
-
-
Christie, J.D.1
Edwards, L.B.2
Kucheryavaya, A.Y.3
Benden, C.4
Dipchand, A.I.5
Dobbels, F.6
-
167
-
-
50249127907
-
The impact of induction on survival after lung transplantation: An analysis of the International Society for Heart and Lung Transplantation Registry
-
18435784
-
Hachem RR, Edwards LB, Yusen RD, Chakinala MM, Alexander Patterson G, Trulock EP. The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry. Clin Transplant. 2008;22:603-8.
-
(2008)
Clin Transplant
, vol.22
, pp. 603-608
-
-
Hachem, R.R.1
Edwards, L.B.2
Yusen, R.D.3
Chakinala, M.M.4
Alexander Patterson, G.5
Trulock, E.P.6
-
168
-
-
0032808199
-
Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: Results of a randomized, prospective study
-
10424515 1:STN:280:DyaK1MzltFyjsw%3D%3D
-
Palmer SM, Miralles AP, Lawrence CM, Gaynor JW, Davis RD, Tapson VF. Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study. Chest. 1999;116:127-33.
-
(1999)
Chest.
, vol.116
, pp. 127-133
-
-
Palmer, S.M.1
Miralles, A.P.2
Lawrence, C.M.3
Gaynor, J.W.4
Davis, R.D.5
Tapson, V.F.6
-
169
-
-
0345352753
-
Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: One-year results of a 2-center prospective randomized trial
-
12698153 1:CAS:528:DC%2BD3sXjslSmsLw%3D
-
Zuckermann A, Reichenspurner H, Birsan T, Treede H, Deviatko E, Reichart B, et al. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial. J Thorac Cardiovasc Surg. 2003;125:891-900.
-
(2003)
J Thorac Cardiovasc Surg.
, vol.125
, pp. 891-900
-
-
Zuckermann, A.1
Reichenspurner, H.2
Birsan, T.3
Treede, H.4
Deviatko, E.5
Reichart, B.6
-
170
-
-
42649094811
-
Rabbit anti-thymocyte globulin induction therapy does not prolong survival after lung transplantation
-
18442722
-
Hartwig MG, Snyder LD, Appel JZ 3rd, Cantu E 3rd, Lin SS, Palmer SM, et al. Rabbit anti-thymocyte globulin induction therapy does not prolong survival after lung transplantation. J Heart Lung Transplant. 2008;27:547-53.
-
(2008)
J Heart Lung Transplant.
, vol.27
, pp. 547-553
-
-
Hartwig, M.G.1
Snyder, L.D.2
Appel, J.Z.3
Cantu, E.4
Lin, S.S.5
Palmer, S.M.6
-
171
-
-
34247162655
-
A randomized, controlled trial of daclizumab vs anti-thymocyte globulin induction for lung transplantation
-
17449421
-
Mullen JC, Oreopoulos A, Lien DC, Bentley MJ, Modry DL, Stewart K, et al. A randomized, controlled trial of daclizumab vs anti-thymocyte globulin induction for lung transplantation. J Heart Lung Transplant. 2007;26:504-10.
-
(2007)
J Heart Lung Transplant.
, vol.26
, pp. 504-510
-
-
Mullen, J.C.1
Oreopoulos, A.2
Lien, D.C.3
Bentley, M.J.4
Modry, D.L.5
Stewart, K.6
-
172
-
-
80054998421
-
Thymoglobulin versus basiliximab induction therapy for simultaneous kidney-pancreas transplantation: Impact on rejection, graft function, and long-term outcome
-
22002345 1:CAS:528:DC%2BC3MXhtlygtr3I
-
Bazerbachi F, Selzner M, Boehnert MU, Marquez MA, Norgate A, McGilvray ID, et al. Thymoglobulin versus basiliximab induction therapy for simultaneous kidney-pancreas transplantation: impact on rejection, graft function, and long-term outcome. Transplantation. 2011;92:1039-43.
-
(2011)
Transplantation.
, vol.92
, pp. 1039-1043
-
-
Bazerbachi, F.1
Selzner, M.2
Boehnert, M.U.3
Marquez, M.A.4
Norgate, A.5
McGilvray, I.D.6
-
173
-
-
0031658162
-
Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation
-
9767555 1:CAS:528:DyaK1cXmslOisr4%3D
-
Cantarovich D, Karam G, Giral-Classe M, Hourmant M, Dantal J, Blancho G, et al. Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation. Kidney Int. 1998;54:1351-6.
-
(1998)
Kidney Int.
, vol.54
, pp. 1351-1356
-
-
Cantarovich, D.1
Karam, G.2
Giral-Classe, M.3
Hourmant, M.4
Dantal, J.5
Blancho, G.6
-
174
-
-
84910117730
-
CNI- and steroid-free immunosuppression after simultaneous pancreas-kidney transplantation: One-year results of a prospective and randomized study
-
Cantarovich D, Papuchon E, Guillot-Guéguen C, Blancho G, Dantal J, Giral-Classe M, et al. CNI- and steroid-free immunosuppression after simultaneous pancreas-kidney transplantation: one-year results of a prospective and randomized study. Transpl Int. 2013;26 Suppl s2:172.
-
(2013)
Transpl Int.
, vol.26
, pp. 172
-
-
Cantarovich D, P.1
-
175
-
-
0037180936
-
A prospective study of rapid corticosteroid elimination in simultaneous pancreas-kidney transplantation: Comparison of two maintenance immunosuppression protocols: Tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus
-
11821726 1:CAS:528:DC%2BD38XhsVOisrg%3D
-
Kaufman DB, Leventhal JR, Koffron AJ, Gallon LG, Parker MA, Fryer JP, et al. A prospective study of rapid corticosteroid elimination in simultaneous pancreas-kidney transplantation: comparison of two maintenance immunosuppression protocols: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Transplantation. 2002;73:169-77.
-
(2002)
Transplantation.
, vol.73
, pp. 169-177
-
-
Kaufman, D.B.1
Leventhal, J.R.2
Koffron, A.J.3
Gallon, L.G.4
Parker, M.A.5
Fryer, J.P.6
-
176
-
-
33747091276
-
Steroid withdrawal for pancreas after kidney transplantation in recipients on maintenance prednisone immunosuppression
-
16906038 1:CAS:528:DC%2BD28XotVWkt74%3D
-
Fridell JA, Agarwal A, Powelson JA, Goggins WC, Milgrom M, Pescovitz MD, et al. Steroid withdrawal for pancreas after kidney transplantation in recipients on maintenance prednisone immunosuppression. Transplantation. 2006;82:389-92.
-
(2006)
Transplantation.
, vol.82
, pp. 389-392
-
-
Fridell, J.A.1
Agarwal, A.2
Powelson, J.A.3
Goggins, W.C.4
Milgrom, M.5
Pescovitz, M.D.6
-
177
-
-
33847615555
-
Very early steroid withdrawal in simultaneous pancreas-kidney transplants
-
17127698 1:CAS:528:DC%2BD2sXitFyqtrc%3D
-
Aoun M, Eschewege P, Hamoudi Y, Beaudreuil S, Duranteau J, Cheisson G, et al. Very early steroid withdrawal in simultaneous pancreas-kidney transplants. Nephrol Dial Transplant. 2007;22:899-905.
-
(2007)
Nephrol Dial Transplant.
, vol.22
, pp. 899-905
-
-
Aoun, M.1
Eschewege, P.2
Hamoudi, Y.3
Beaudreuil, S.4
Duranteau, J.5
Cheisson, G.6
-
178
-
-
2942687875
-
Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation
-
15194370 1:CAS:528:DC%2BD2cXkvV2hu7g%3D
-
Freise CE, Kang SM, Feng S, Posselt A, Hirose K, Hirose R, et al. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation. Transplant Proc. 2004;36:1067-8.
-
(2004)
Transplant Proc.
, vol.36
, pp. 1067-1068
-
-
Freise, C.E.1
Kang, S.M.2
Feng, S.3
Posselt, A.4
Hirose, K.5
Hirose, R.6
-
179
-
-
77955542619
-
Alemtuzumab with rapid steroid taper in simultaneous kidney and pancreas transplantation: Comparison to induction with antithymocyte globulin
-
20692393 1:CAS:528:DC%2BC3cXpvVyksbg%3D
-
Reddy KS, Devarapalli Y, Mazur M, Hamawi K, Chakkera H, Moss A, et al. Alemtuzumab with rapid steroid taper in simultaneous kidney and pancreas transplantation: comparison to induction with antithymocyte globulin. Transplant Proc. 2010;42:2006-8.
-
(2010)
Transplant Proc.
, vol.42
, pp. 2006-2008
-
-
Reddy, K.S.1
Devarapalli, Y.2
Mazur, M.3
Hamawi, K.4
Chakkera, H.5
Moss, A.6
-
180
-
-
84879553051
-
Multicenter Australian trial of islet transplantation: Improving accessibility and outcomes
-
23668890
-
O'Connell PJ, Holmes-Walker DJ, Goodman D, Hawthorne WJ, Loudovaris T, Gunton JE, et al. Multicenter Australian trial of islet transplantation: improving accessibility and outcomes. Am J Transplant. 2013;13:1850-8.
-
(2013)
Am J Transplant.
, vol.13
, pp. 1850-1858
-
-
O'Connell, P.J.1
Holmes-Walker, D.J.2
Goodman, D.3
Hawthorne, W.J.4
Loudovaris, T.5
Gunton, J.E.6
-
181
-
-
84859310580
-
Islet transplantation in type i diabetes mellitus
-
22461742 1:CAS:528:DC%2BC38XmsF2kur0%3D 3313538
-
Jamiolkowski RM, Guo LY, Li YR, Shaffer SM, Naji A. Islet transplantation in type I diabetes mellitus. Yale J Biol Med. 2012;85:37-43.
-
(2012)
Yale J Biol Med.
, vol.85
, pp. 37-43
-
-
Jamiolkowski, R.M.1
Guo, L.Y.2
Li, Y.R.3
Shaffer, S.M.4
Naji, A.5
-
182
-
-
77954598684
-
Intestine and multivisceral transplantation in the United States: A report of 20-year national registry data (1990-2009)
-
Cai J. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009). Clin Transplant. 2009;83-101.
-
(2009)
Clin Transplant
, pp. 83-101
-
-
Cai, J.1
-
183
-
-
78751641946
-
Graft-versus-host disease after intestinal and multivisceral transplantation
-
21076376
-
Wu G, Selvaggi G, Nishida S, Moon J, Island E, Ruiz P, et al. Graft-versus-host disease after intestinal and multivisceral transplantation. Transplantation. 2011;91:219-24.
-
(2011)
Transplantation
, vol.91
, pp. 219-224
-
-
Wu, G.1
Selvaggi, G.2
Nishida, S.3
Moon, J.4
Island, E.5
Ruiz, P.6
-
184
-
-
43449133599
-
Induction immunosuppression with thymoglobulin and rituximab in intestinal and multivisceral transplantation
-
18475186 1:CAS:528:DC%2BD1cXlslKhs7c%3D
-
Vianna RM, Mangus RS, Fridell JA, Weigman S, Kazimi M, Tector J. Induction immunosuppression with thymoglobulin and rituximab in intestinal and multivisceral transplantation. Transplantation. 2008;85:1290-3.
-
(2008)
Transplantation
, vol.85
, pp. 1290-1293
-
-
Vianna, R.M.1
Mangus, R.S.2
Fridell, J.A.3
Weigman, S.4
Kazimi, M.5
Tector, J.6
-
185
-
-
84874813493
-
Intestinal and multivisceral transplantation immunosuppression protocols: Literature review
-
23026616 1:STN:280:DC%2BC3s%2FhsFOltw%3D%3D
-
Trevizol AP, David AI, Dias ER, Mantovani D, Pécora R, D'Albuquerque LA. Intestinal and multivisceral transplantation immunosuppression protocols: literature review. Transplant Proc. 2012;44:2445-8.
-
(2012)
Transplant Proc
, vol.44
, pp. 2445-2448
-
-
Trevizol, A.P.1
David, A.I.2
Dias, E.R.3
Mantovani, D.4
Pécora, R.5
D'Albuquerque, L.A.6
-
186
-
-
57349133153
-
Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance
-
18954362
-
Abu-Elmagd KM, Costa G, Bond GJ, Wu T, Murase N, Zeevi A, et al. Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance. Transpl Int. 2009;22:96-109.
-
(2009)
Transpl Int
, vol.22
, pp. 96-109
-
-
Abu-Elmagd, K.M.1
Costa, G.2
Bond, G.J.3
Wu, T.4
Murase, N.5
Zeevi, A.6
-
187
-
-
84879148111
-
A decade of experience with a single dose of rabbit antithymocyte globulin or alemtuzumab pretreatment for intestinal and multivisceral transplantation
-
Abu-Elmagd KM, Costa G, Bond GJ, Soltys K, Martin L, Koritsky DA, et al. A decade of experience with a single dose of rabbit antithymocyte globulin or alemtuzumab pretreatment for intestinal and multivisceral transplantation. Clin Transplant. 2012:155-66.
-
(2012)
Clin Transplant
, pp. 155-166
-
-
Abu-Elmagd, K.M.1
Costa, G.2
Bond, G.J.3
Soltys, K.4
Martin, L.5
Koritsky, D.A.6
-
188
-
-
84878624342
-
Vascularized composite tissue allotransplantation: State of the art
-
23581799 3724233
-
Diaz-Siso JR, Bueno EM, Sisk GC, Marty FM, Pomahac B, Tullius SG. Vascularized composite tissue allotransplantation: state of the art. Clin Transplant. 2013;27:330-7.
-
(2013)
Clin Transplant
, vol.27
, pp. 330-337
-
-
Diaz-Siso, J.R.1
Bueno, E.M.2
Sisk, G.C.3
Marty, F.M.4
Pomahac, B.5
Tullius, S.G.6
-
189
-
-
84885435179
-
Vascularized composite allotransplantation: An update on medical and surgical progress and remaining challenges
-
23867239
-
Murphy BD, Zuker RM, Borschel GH. Vascularized composite allotransplantation: an update on medical and surgical progress and remaining challenges. J Plast Reconstr Aesthet Surg. 2013;66:1449-55.
-
(2013)
J Plast Reconstr Aesthet Surg
, vol.66
, pp. 1449-1455
-
-
Murphy, B.D.1
Zuker, R.M.2
Borschel, G.H.3
-
190
-
-
33745828140
-
First human face allograft: Early report
-
16844489
-
Devauchelle B, Badet L, Lengelé B, Morelon E, Testelin S, Michallet M, et al. First human face allograft: early report. Lancet. 2006;368:203-9.
-
(2006)
Lancet
, vol.368
, pp. 203-209
-
-
Devauchelle, B.1
Badet, L.2
Lengelé, B.3
Morelon, E.4
Testelin, S.5
Michallet, M.6
-
191
-
-
84855847308
-
First human face transplantation: 5 years outcomes
-
22167048
-
Petruzzo P, Testelin S, Kanitakis J, Badet L, Lengelé B, Girbon JP, et al. First human face transplantation: 5 years outcomes. Transplantation. 2012;93:236-40.
-
(2012)
Transplantation
, vol.93
, pp. 236-240
-
-
Petruzzo, P.1
Testelin, S.2
Kanitakis, J.3
Badet, L.4
Lengelé, B.5
Girbon, J.P.6
-
192
-
-
75149122551
-
First U.S. near-total human face transplantation: A paradigm shift for massive complex injuries
-
19770815 1:CAS:528:DC%2BC3cXnvFyk
-
Siemionow MZ, Papay F, Djohan R, Bernard S, Gordon CR, Alam D, et al. First U.S. near-total human face transplantation: a paradigm shift for massive complex injuries. Plast Reconstr Surg. 2010;125:111-22.
-
(2010)
Plast Reconstr Surg
, vol.125
, pp. 111-122
-
-
Siemionow, M.Z.1
Papay, F.2
Djohan, R.3
Bernard, S.4
Gordon, C.R.5
Alam, D.6
-
193
-
-
79961093769
-
Full face transplant: The first case report
-
21772126
-
Barret JP, Gavaldà J, Bueno J, Nuvials X, Pont T, Masnou N, et al. Full face transplant: the first case report. Ann Surg. 2011;254:252-6.
-
(2011)
Ann Surg
, vol.254
, pp. 252-256
-
-
Barret, J.P.1
Gavaldà, J.2
Bueno, J.3
Nuvials, X.4
Pont, T.5
Masnou, N.6
-
194
-
-
0033577486
-
Human hand allograft: Report on first 6 months
-
10218530 1:STN:280:DyaK1M3jt1yqug%3D%3D
-
Dubernard JM, Owen E, Herzberg G, Lanzetta M, Martin X, Kapila H, et al. Human hand allograft: report on first 6 months. Lancet. 1999;353:1315-20.
-
(1999)
Lancet
, vol.353
, pp. 1315-1320
-
-
Dubernard, J.M.1
Owen, E.2
Herzberg, G.3
Lanzetta, M.4
Martin, X.5
Kapila, H.6
-
195
-
-
39649100164
-
Atypical acute rejection after hand transplantation
-
18261182 1:STN:280:DC%2BD1c7jsFKntg%3D%3D
-
Schneeberger S, Gorantla VS, van Riet RP, Lanzetta M, Vereecken P, van Holder C, et al. Atypical acute rejection after hand transplantation. Am J Transplant. 2008;8:688-96.
-
(2008)
Am J Transplant
, vol.8
, pp. 688-696
-
-
Schneeberger, S.1
Gorantla, V.S.2
Van Riet, R.P.3
Lanzetta, M.4
Vereecken, P.5
Van Holder, C.6
-
196
-
-
84860769966
-
Immunological issues in clinical composite tissue allotransplantation: Where do we stand today?
-
22538449 1:CAS:528:DC%2BC38Xmt1KrtLY%3D
-
Morelon E, Kanitakis J, Petruzzo P. Immunological issues in clinical composite tissue allotransplantation: where do we stand today? Transplantation. 2012;93:855-9.
-
(2012)
Transplantation
, vol.93
, pp. 855-859
-
-
Morelon, E.1
Kanitakis, J.2
Petruzzo, P.3
-
197
-
-
80355135138
-
Spectrum of cancer risk among US solid organ transplant recipients
-
22045767 1:CAS:528:DC%2BC3MXhsVKnsb7L 3310893
-
Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011;306:1891-901.
-
(2011)
JAMA
, vol.306
, pp. 1891-1901
-
-
Engels, E.A.1
Pfeiffer, R.M.2
Fraumeni, J.F.3
Kasiske, B.L.4
Israni, A.K.5
Snyder, J.J.6
-
198
-
-
35248887465
-
Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab
-
17868060 1:CAS:528:DC%2BD2sXhtlakt73F 2778321
-
Kirk AD, Cherikh WS, Ring M, Burke G, Kaufman D, Knechtle SJ, et al. Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab. Am J Transplant. 2007;7:2619-25.
-
(2007)
Am J Transplant
, vol.7
, pp. 2619-2625
-
-
Kirk, A.D.1
Cherikh, W.S.2
Ring, M.3
Burke, G.4
Kaufman, D.5
Knechtle, S.J.6
-
199
-
-
84857526313
-
French Transplant Centers. Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: Report of the French registry and analysis of subgroups of lymphomas
-
22226336 1:CAS:528:DC%2BC38XlvVGmt7g%3D
-
Caillard S, Lamy FX, Quelen C, Dantal J, Lebranchu Y, Lang P, et al. French Transplant Centers. Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas. Am J Transplant. 2012;12:682-93.
-
(2012)
Am J Transplant
, vol.12
, pp. 682-693
-
-
Caillard, S.1
Lamy, F.X.2
Quelen, C.3
Dantal, J.4
Lebranchu, Y.5
Lang, P.6
-
200
-
-
77949348503
-
Impact of HLA mismatching on incidence of posttransplant non-hodgkin lymphoma after kidney transplantation
-
20110857 1:CAS:528:DC%2BC3cXivV2ksbY%3D
-
Opelz G, Döhler B. Impact of HLA mismatching on incidence of posttransplant non-hodgkin lymphoma after kidney transplantation. Transplantation. 2010;89:567-72.
-
(2010)
Transplantation
, vol.89
, pp. 567-572
-
-
Opelz, G.1
Döhler, B.2
-
201
-
-
79959205026
-
Steering Group, UK Cardiothoracic Transplant Audit. Antithymocyte globulin therapy for adult heart transplantation: A UK national study
-
21444210
-
Emin A, Rogers C, Thekkudan J, Bonser RS, Banner NR. Steering Group, UK Cardiothoracic Transplant Audit. Antithymocyte globulin therapy for adult heart transplantation: a UK national study. J Heart Lung Transplant. 2011;30:770-7.
-
(2011)
J Heart Lung Transplant
, vol.30
, pp. 770-777
-
-
Emin, A.1
Rogers, C.2
Thekkudan, J.3
Bonser, R.S.4
Banner, N.R.5
-
202
-
-
79551684833
-
Pediatric Heart Transplant Study Investigators. Infection and malignancy after pediatric transplantation: The role of induction therapy
-
21115369
-
Gajarski R, Blume E, Urschel S, Schechtman K, Zheng J, West LJ, et al. Pediatric Heart Transplant Study Investigators. Infection and malignancy after pediatric transplantation: the role of induction therapy. J Heart Lung Transplant. 2011;30:299-308.
-
(2011)
J Heart Lung Transplant
, vol.30
, pp. 299-308
-
-
Gajarski, R.1
Blume, E.2
Urschel, S.3
Schechtman, K.4
Zheng, J.5
West, L.J.6
-
203
-
-
0742301290
-
Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients
-
14678038
-
Bustami RT, Ojo AO, Wolfe RA, Merion RM, Bennett WM, McDiarmid SV, et al. Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant. 2004;4:87-93.
-
(2004)
Am J Transplant
, vol.4
, pp. 87-93
-
-
Bustami, R.T.1
Ojo, A.O.2
Wolfe, R.A.3
Merion, R.M.4
Bennett, W.M.5
McDiarmid, S.V.6
-
204
-
-
65549108756
-
An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States
-
19352121
-
Dharnidharka VR, Cherikh WS, Abbott KC. An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States. Transplantation. 2009;87:1019-26.
-
(2009)
Transplantation
, vol.87
, pp. 1019-1026
-
-
Dharnidharka, V.R.1
Cherikh, W.S.2
Abbott, K.C.3
-
205
-
-
65549095916
-
Treatment for BK virus: Incidence, risk factors, and outcomes for kidney transplant recipients in the United States
-
19207187
-
Schold JD, Rehman S, Kayle LK, Magliocca J, Srinivas TR, Meier-Kriesche HU. Treatment for BK virus: incidence, risk factors, and outcomes for kidney transplant recipients in the United States. Transpl Int. 2009;22:626-34.
-
(2009)
Transpl Int
, vol.22
, pp. 626-634
-
-
Schold, J.D.1
Rehman, S.2
Kayle, L.K.3
Magliocca, J.4
Srinivas, T.R.5
Meier-Kriesche, H.U.6
-
206
-
-
84899477309
-
Acute rejection, T-cell-depleting antibodies, and cancer after transplantation
-
24521777 1:CAS:528:DC%2BC2cXmtFaisLw%3D
-
Lim WH, Turner RM, Chapman JR, Ma MK, Webster AC, Craig JC, et al. Acute rejection, T-cell-depleting antibodies, and cancer after transplantation. Transplantation. 2014;97:817-25.
-
(2014)
Transplantation
, vol.97
, pp. 817-825
-
-
Lim, W.H.1
Turner, R.M.2
Chapman, J.R.3
Ma, M.K.4
Webster, A.C.5
Craig, J.C.6
-
207
-
-
84899485405
-
T-cell-depleting antibodies and risk of cancer after transplantation
-
24670299
-
Snanoudj R, Legendre C. T-cell-depleting antibodies and risk of cancer after transplantation. Transplantation. 2014;97:808-9.
-
(2014)
Transplantation
, vol.97
, pp. 808-809
-
-
Snanoudj, R.1
Legendre, C.2
-
208
-
-
79959390947
-
Posttransplantation lymphoproliferative disorder in kidney and heart transplant recipients receiving thymoglobulin: A systematic review
-
21693205 1:STN:280:DC%2BC3MnisVCmsg%3D%3D
-
Marks WH, Ilsley JN, Dharnidharka VR. Posttransplantation lymphoproliferative disorder in kidney and heart transplant recipients receiving thymoglobulin: a systematic review. Transplant Proc. 2011;43:1395-404.
-
(2011)
Transplant Proc
, vol.43
, pp. 1395-1404
-
-
Marks, W.H.1
Ilsley, J.N.2
Dharnidharka, V.R.3
-
209
-
-
1342304173
-
Lymphomas after solid organ transplantation: A collaborative transplant study report
-
14974943
-
Opelz G, Döhler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant. 2004;4:222-30.
-
(2004)
Am J Transplant
, vol.4
, pp. 222-230
-
-
Opelz, G.1
Döhler, B.2
-
210
-
-
28544449370
-
Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression
-
16314791 1:CAS:528:DC%2BD2MXht1Gru7nP
-
Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation. 2005;80:1233-43.
-
(2005)
Transplantation
, vol.80
, pp. 1233-1243
-
-
Caillard, S.1
Dharnidharka, V.2
Agodoa, L.3
Bohen, E.4
Abbott, K.5
-
211
-
-
0242491828
-
Association of the type of and induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation
-
14627905 1:CAS:528:DC%2BD3sXptV2jtro%3D
-
Cherikh WS, Kauffman HM, McBride MA, Maghirang J, Swinnen LJ, Hanto DW. Association of the type of and induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation. 2003;76:1289-93.
-
(2003)
Transplantation
, vol.76
, pp. 1289-1293
-
-
Cherikh, W.S.1
Kauffman, H.M.2
McBride, M.A.3
Maghirang, J.4
Swinnen, L.J.5
Hanto, D.W.6
-
212
-
-
26244441337
-
Risk for post-transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation
-
16176420
-
Dharnidharka VR, Stevens G. Risk for post-transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation. Pediatr Transplant. 2005;9:622-6.
-
(2005)
Pediatr Transplant
, vol.9
, pp. 622-626
-
-
Dharnidharka, V.R.1
Stevens, G.2
-
213
-
-
23044483855
-
Lymphoproliferative disease after renal transplantation in Australia and New Zealand
-
16041263
-
Faull RJ, Hollett P, McDonald SP. Lymphoproliferative disease after renal transplantation in Australia and New Zealand. Transplantation. 2005;80:193-7.
-
(2005)
Transplantation
, vol.80
, pp. 193-197
-
-
Faull, R.J.1
Hollett, P.2
McDonald, S.P.3
-
214
-
-
52449116522
-
Epidemiology of BK virus in renal allograft recipients: Independent risk factors for BK virus replication
-
18724220 3647687
-
Dadhania D, Snopkowski C, Ding R, Muthukumar T, Chang C, Aull M, et al. Epidemiology of BK virus in renal allograft recipients: independent risk factors for BK virus replication. Transplantation. 2008;86:521-8.
-
(2008)
Transplantation
, vol.86
, pp. 521-528
-
-
Dadhania, D.1
Snopkowski, C.2
Ding, R.3
Muthukumar, T.4
Chang, C.5
Aull, M.6
-
215
-
-
84880094832
-
Risk factors for BK virus infection in the era of therapeutic drug monitoring
-
23778568 1:CAS:528:DC%2BC3sXpvVOktLs%3D
-
Borni-Duval C, Caillard S, Olagne J, Perrin P, Braun-Parvez L, Heibel F, et al. Risk factors for BK virus infection in the era of therapeutic drug monitoring. Transplantation. 2013;95:1498-505.
-
(2013)
Transplantation
, vol.95
, pp. 1498-1505
-
-
Borni-Duval, C.1
Caillard, S.2
Olagne, J.3
Perrin, P.4
Braun-Parvez, L.5
Heibel, F.6
-
216
-
-
65649142921
-
The decade of polyomavirus BK-associated nephropathy: State of affairs
-
19295303
-
Ramos E, Drachenberg CB, Wali R, Hirsch HH. The decade of polyomavirus BK-associated nephropathy: state of affairs. Transplantation. 2009;87:621-30.
-
(2009)
Transplantation
, vol.87
, pp. 621-630
-
-
Ramos, E.1
Drachenberg, C.B.2
Wali, R.3
Hirsch, H.H.4
-
217
-
-
84859400510
-
BK virus replication following kidney transplant: Does the choice of immunosuppressive regimen influence outcomes?
-
22466913 1:CAS:528:DC%2BC38Xht1OnsLfL
-
Acott P, Babel N. BK virus replication following kidney transplant: does the choice of immunosuppressive regimen influence outcomes? Ann Transplant. 2012;17:86-99.
-
(2012)
Ann Transplant
, vol.17
, pp. 86-99
-
-
Acott, P.1
Babel, N.2
-
218
-
-
62449171076
-
Infectious complications of antilymphocyte therapies in solid organ transplantation
-
19207081 1:CAS:528:DC%2BD1MXktVyrsbk%3D
-
Issa NC, Fishman JA. Infectious complications of antilymphocyte therapies in solid organ transplantation. Clin Infect Dis. 2009;48:772-86.
-
(2009)
Clin Infect Dis
, vol.48
, pp. 772-786
-
-
Issa, N.C.1
Fishman, J.A.2
-
219
-
-
0032758059
-
Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation
-
10516691 1:STN:280:DyaK1MvkslGnsQ%3D%3D
-
Remberger M, Svahn BM, Hentschke P, Löfgren C, Ringdén O. Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation. Bone Marrow Transplant. 1999;24:823-30.
-
(1999)
Bone Marrow Transplant
, vol.24
, pp. 823-830
-
-
Remberger, M.1
Svahn, B.M.2
Hentschke, P.3
Löfgren, C.4
Ringdén, O.5
-
220
-
-
0035892107
-
Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)
-
11698275 1:CAS:528:DC%2BD3MXosFyns7k%3D
-
Bacigalupo A, Lamparelli T, Bruzzi P, Guidi S, Alessandrino PE, di Bartolomeo P, et al. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). Blood. 2001;98:2942-7.
-
(2001)
Blood
, vol.98
, pp. 2942-2947
-
-
Bacigalupo, A.1
Lamparelli, T.2
Bruzzi, P.3
Guidi, S.4
Alessandrino, P.E.5
Di Bartolomeo, P.6
-
221
-
-
33745449021
-
Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: Long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation
-
16635791
-
Bacigalupo A, Lamparelli T, Barisione G, Bruzzi P, Guidi S, Alessandrino PE, et al. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Biol Blood Marrow Transplant. 2006;12:560-5.
-
(2006)
Biol Blood Marrow Transplant
, vol.12
, pp. 560-565
-
-
Bacigalupo, A.1
Lamparelli, T.2
Barisione, G.3
Bruzzi, P.4
Guidi, S.5
Alessandrino, P.E.6
-
222
-
-
0036861875
-
Unrelated donor BMT recipients given pretransplant low dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: A matched pair analysis
-
12420207 1:STN:280:DC%2BD38nlvFCjtg%3D%3D
-
Duggan P, Booth K, Chaudhry A, Stewart D, Ruether JD, Glück S, et al. Unrelated donor BMT recipients given pretransplant low dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis. Bone Marrow Transplant. 2002;30:681-6.
-
(2002)
Bone Marrow Transplant
, vol.30
, pp. 681-686
-
-
Duggan, P.1
Booth, K.2
Chaudhry, A.3
Stewart, D.4
Ruether, J.D.5
Glück, S.6
-
223
-
-
85047698374
-
Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors
-
11919728 1:STN:280:DC%2BD387os1Ojtw%3D%3D
-
Remberger M, Storer B, Ringdén O, Anasetti C. Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors. Bone Marrow Transplant. 2002;29:391-7.
-
(2002)
Bone Marrow Transplant
, vol.29
, pp. 391-397
-
-
Remberger, M.1
Storer, B.2
Ringdén, O.3
Anasetti, C.4
-
224
-
-
33745470309
-
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen
-
16635793 1:CAS:528:DC%2BD28Xltlart70%3D
-
Deeg HJ, Storer BE, Boeckh M, Martin PJ, McCune JS, Myerson D, et al. Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen. Biol Blood Marrow Transplant. 2006;12:573-84.
-
(2006)
Biol Blood Marrow Transplant
, vol.12
, pp. 573-584
-
-
Deeg, H.J.1
Storer, B.E.2
Boeckh, M.3
Martin, P.J.4
McCune, J.S.5
Myerson, D.6
-
225
-
-
58249138311
-
Total and active rabbit antithymocyte globulin (rATG; Thymoglobulin) pharmacokinetics in pediatric patients undergoing unrelated donor bone marrow transplantation
-
19167688 1:CAS:528:DC%2BD1MXjtVyiurs%3D
-
Call SK, Kasow KA, Barfield R, Madden R, Leung W, Horwitz E, et al. Total and active rabbit antithymocyte globulin (rATG; Thymoglobulin) pharmacokinetics in pediatric patients undergoing unrelated donor bone marrow transplantation. Biol Blood Marrow Transplant. 2009;15:274-8.
-
(2009)
Biol Blood Marrow Transplant
, vol.15
, pp. 274-278
-
-
Call, S.K.1
Kasow, K.A.2
Barfield, R.3
Madden, R.4
Leung, W.5
Horwitz, E.6
-
226
-
-
33847046703
-
Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: A matched pair analysis
-
17317583 1:CAS:528:DC%2BD2sXjvFKqu7g%3D
-
Russell JA, Turner AR, Larratt L, Chaudhry A, Morris D, Brown C, et al. Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis. Biol Blood Marrow Transplant. 2007;13:299-306.
-
(2007)
Biol Blood Marrow Transplant
, vol.13
, pp. 299-306
-
-
Russell, J.A.1
Turner, A.R.2
Larratt, L.3
Chaudhry, A.4
Morris, D.5
Brown, C.6
-
227
-
-
47249129071
-
Transplantation from matched siblings using once-daily intravenous busulfan/fludarabine with thymoglobulin: A myeloablative regimen with low nonrelapse mortality in all but older patients with high-risk disease
-
18640572 1:CAS:528:DC%2BD1cXhtVeisLzJ
-
Russell JA, Duan Q, Chaudhry MA, Savoie ML, Balogh A, Turner AR, et al. Transplantation from matched siblings using once-daily intravenous busulfan/fludarabine with thymoglobulin: a myeloablative regimen with low nonrelapse mortality in all but older patients with high-risk disease. Biol Blood Marrow Transplant. 2008;14:888-95.
-
(2008)
Biol Blood Marrow Transplant
, vol.14
, pp. 888-895
-
-
Russell, J.A.1
Duan, Q.2
Chaudhry, M.A.3
Savoie, M.L.4
Balogh, A.5
Turner, A.R.6
-
228
-
-
84871922030
-
French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: Lessons and future directions
-
Galambrun C, Pondarré C, Bertrand Y, Loundou A, Bordigoni P, Frange P, et al. French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: lessons and future directions. Biol Blood Marrow Transpl. 2013;9:62-8.
-
(2013)
Biol Blood Marrow Transpl
, vol.9
, pp. 62-68
-
-
Galambrun, C.1
Pondarré, C.2
Bertrand, Y.3
Loundou, A.4
Bordigoni, P.5
Frange, P.6
-
229
-
-
84867444863
-
Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation
-
22710143 1:CAS:528:DC%2BC38XhsFSltb7P 3777606
-
Al-Kadhimi Z, Gul Z, Rodriguez R, Chen W, Smith D, Mitchell A, et al. Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2012;18:1734-44.
-
(2012)
Biol Blood Marrow Transplant
, vol.18
, pp. 1734-1744
-
-
Al-Kadhimi, Z.1
Gul, Z.2
Rodriguez, R.3
Chen, W.4
Smith, D.5
Mitchell, A.6
-
230
-
-
34248343471
-
Busulphan in blood and marrow transplantation: Dose, route, frequency and role of therapeutic drug monitoring
-
18690856 1:CAS:528:DC%2BD2sXjsVOhurY%3D
-
Nath CE, Shaw PJ. Busulphan in blood and marrow transplantation: dose, route, frequency and role of therapeutic drug monitoring. Curr Clin Pharmacol. 2007;2:75-91.
-
(2007)
Curr Clin Pharmacol
, vol.2
, pp. 75-91
-
-
Nath, C.E.1
Shaw, P.J.2
-
231
-
-
77956570203
-
Advances in umbilical cord transplantation: The role of thymoglobulin/ATG in cord blood transplantation
-
Mohty M, Gaugler B. Advances in umbilical cord transplantation: the role of thymoglobulin/ATG in cord blood transplantation. Best Pract Res Clin Haematol. 2010;23:275-82.
-
(2010)
Best Pract Res Clin Haematol
, vol.23
, pp. 275-282
-
-
Mohty, M.1
Gaugler, B.2
-
232
-
-
0038156372
-
Graft-versus- host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen
-
12649133 1:CAS:528:DC%2BD3sXlslGitro%3D
-
Mohty M, Bay JO, Faucher C, Choufi B, Bilger K, Tournilhac O, et al. Graft-versus- host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen. Blood. 2003;102:470-6.
-
(2003)
Blood
, vol.102
, pp. 470-476
-
-
Mohty, M.1
Bay, J.O.2
Faucher, C.3
Choufi, B.4
Bilger, K.5
Tournilhac, O.6
-
233
-
-
25444461935
-
Protective conditioning for acute graft-versus-host disease
-
16192477 1:CAS:528:DC%2BD2MXhtVGgtb3O
-
Lowsky R, Takahashi T, Liu YP, Dejbakhsh-Jones S, Grumet FC, Shizuru JA, et al. Protective conditioning for acute graft-versus-host disease. N Engl J Med. 2005;353:1321-31.
-
(2005)
N Engl J Med
, vol.353
, pp. 1321-1331
-
-
Lowsky, R.1
Takahashi, T.2
Liu, Y.P.3
Dejbakhsh-Jones, S.4
Grumet, F.C.5
Shizuru, J.A.6
-
234
-
-
84860009428
-
Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant
-
22023525 1:CAS:528:DC%2BC38XlvFWht7c%3D 3894827
-
Bashir Q, Munsell MF, Giralt S, de Padua Silva L, Sharma M, Couriel D, et al. Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant. Leuk Lymphoma. 2012;53:915-9.
-
(2012)
Leuk Lymphoma
, vol.53
, pp. 915-919
-
-
Bashir, Q.1
Munsell, M.F.2
Giralt, S.3
De Padua Silva, L.4
Sharma, M.5
Couriel, D.6
-
235
-
-
84881551281
-
A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donors
-
23701240 1:CAS:528:DC%2BC3sXhsFKlur3I
-
Remberger M, Ringdén O, Hägglund H, Svahn BM, Ljungman P, Uhlin M, et al. A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donors. Clin Transplant. 2013;27:E368-74.
-
(2013)
Clin Transplant
, vol.27
, pp. 368-E374
-
-
Remberger, M.1
Ringdén, O.2
Hägglund, H.3
Svahn, B.M.4
Ljungman, P.5
Uhlin, M.6
-
236
-
-
84872926398
-
Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation: Prospective clinical and socioeconomic evaluation
-
22893313 1:CAS:528:DC%2BC3sXhsVWku7Y%3D
-
Blaise D, Tabrizi R, Boher JM, Le Corroller-Soriano AG, Bay JO, Fegueux N, et al. Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation: prospective clinical and socioeconomic evaluation. Cancer. 2013;119:602-11.
-
(2013)
Cancer
, vol.119
, pp. 602-611
-
-
Blaise, D.1
Tabrizi, R.2
Boher, J.M.3
Le Corroller-Soriano, A.G.4
Bay, J.O.5
Fegueux, N.6
-
237
-
-
33645321155
-
Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML
-
16327813 1:CAS:528:DC%2BD28XntFSgug%3D%3D
-
Horn B, Baxter-Lower LA, Englert L, McMillan A, Quinn M, Desantes K, et al. Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML. Bone Marrow Transplant. 2006;37:263-9.
-
(2006)
Bone Marrow Transplant
, vol.37
, pp. 263-269
-
-
Horn, B.1
Baxter-Lower, L.A.2
Englert, L.3
McMillan, A.4
Quinn, M.5
Desantes, K.6
-
238
-
-
10744224819
-
A revised day +7 predictive score for transplant-related mortality: Serum cholinesterase, total protein, blood urea nitrogen, gamma glutamil transferase, donor type and cell dose
-
12838286 1:STN:280:DC%2BD3szlt1Slsw%3D%3D
-
Sormani MP, Oneto R, Bruno B, Fiorone M, Lamparelli T, Gualandi F, et al. A revised day +7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, gamma glutamil transferase, donor type and cell dose. Bone Marrow Transplant. 2003;32:205-11.
-
(2003)
Bone Marrow Transplant
, vol.32
, pp. 205-211
-
-
Sormani, M.P.1
Oneto, R.2
Bruno, B.3
Fiorone, M.4
Lamparelli, T.5
Gualandi, F.6
-
239
-
-
76749165710
-
Gruppo Italiano Trapianto Midollo Osseo (GITMO). Pre-emptive treatment of acute GVHD: A randomized multicenter trial of rabbit anti-thymocyte globulin, given on day + 7 after alternative donor transplants
-
19584823 1:STN:280:DC%2BC3c%2FpsFyjug%3D%3D
-
Bacigalupo A, Lamparelli T, Milone G, Sormani MP, Ciceri F, Peccatori J, et al. Gruppo Italiano Trapianto Midollo Osseo (GITMO). Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day +7 after alternative donor transplants. Bone Marrow Transplant. 2010;45:385-91.
-
(2010)
Bone Marrow Transplant
, vol.45
, pp. 385-391
-
-
Bacigalupo, A.1
Lamparelli, T.2
Milone, G.3
Sormani, M.P.4
Ciceri, F.5
Peccatori, J.6
-
240
-
-
33646548277
-
Treatment of acute graft-versus-host disease with prednisolone: Significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin
-
16449522
-
Van Lint MT, Milone G, Leotta S, Uderzo C, Scime R, Dallorso S, et al. Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin. Blood. 2006;107:4177-81.
-
(2006)
Blood
, vol.107
, pp. 4177-4181
-
-
Van Lint, M.T.1
Milone, G.2
Leotta, S.3
Uderzo, C.4
Scime, R.5
Dallorso, S.6
-
241
-
-
4644356472
-
Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease
-
15389432 1:CAS:528:DC%2BD2cXpsl2gtbs%3D
-
Antin JH, Chen AR, Couriel DR, Ho VT, Nash RA, Weisdorf D. Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease. Biol Blood Marrow Transplant. 2004;10:655-68.
-
(2004)
Biol Blood Marrow Transplant
, vol.10
, pp. 655-668
-
-
Antin, J.H.1
Chen, A.R.2
Couriel, D.R.3
Ho, V.T.4
Nash, R.A.5
Weisdorf, D.6
-
242
-
-
0035883085
-
Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and qualitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT
-
11493441
-
Van Esser JW, van der Holt B, Meijer E, Niesters HG, Trenschel R, Thijsen SF, et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and qualitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood. 2001;98:972-8.
-
(2001)
Blood
, vol.98
, pp. 972-978
-
-
Van Esser, J.W.1
Van Der Holt, B.2
Meijer, E.3
Niesters, H.G.4
Trenschel, R.5
Thijsen, S.F.6
-
243
-
-
84855744204
-
In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCT
-
21460867 1:CAS:528:DC%2BC38XntFOhug%3D%3D
-
Dominietto A, Tedone E, Soracco M, Bruno B, Raiola AM, Van Lint MT, et al. In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCT. Bone Marrow Transplant. 2012;47:101-6.
-
(2012)
Bone Marrow Transplant
, vol.47
, pp. 101-106
-
-
Dominietto, A.1
Tedone, E.2
Soracco, M.3
Bruno, B.4
Raiola, A.M.5
Van Lint, M.T.6
-
244
-
-
34248376573
-
Bone marrow transplantation for severe aplastic anemia: A randomized controlled study of conditioning regimens
-
17272503 1:CAS:528:DC%2BD2sXls1amtrk%3D 1885491
-
Champlin RE, Perez WS, Passweg JR, Klein JP, Camitta BM, Gluckman E, et al. Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens. Blood. 2007;109:4582-5.
-
(2007)
Blood
, vol.109
, pp. 4582-4585
-
-
Champlin, R.E.1
Perez, W.S.2
Passweg, J.R.3
Klein, J.P.4
Camitta, B.M.5
Gluckman, E.6
-
245
-
-
84864762897
-
Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation (WPSAA-EBMT). Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: Survival advantage for bone marrow in all age groups
-
22315497 1:CAS:528:DC%2BC3sXjs1SlsQ%3D%3D 3409810
-
Bacigalupo A, Socié G, Schrezenmeier H, Tichelli A, Locasciulli A, Fuehrer M, et al. Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation (WPSAA-EBMT). Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups. Haematologica. 2012;97:1142-8.
-
(2012)
Haematologica
, vol.97
, pp. 1142-1148
-
-
Bacigalupo, A.1
Socié, G.2
Schrezenmeier, H.3
Tichelli, A.4
Locasciulli, A.5
Fuehrer, M.6
-
246
-
-
77953184315
-
Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: A retrospective study from the EBMT-SAA working party
-
20494932 1:CAS:528:DC%2BC3cXhtlShu77E 2878797
-
Bacigalupo A, Socie' G, Lanino E, Prete A, Locatelli F, Locasciulli A, et al. Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party. Haematologica. 2010;95:976-82.
-
(2010)
Haematologica
, vol.95
, pp. 976-982
-
-
Bacigalupo, A.1
Socie, G.2
Lanino, E.3
Prete, A.4
Locatelli, F.5
Locasciulli, A.6
-
247
-
-
77957751201
-
Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study
-
20685256 1:CAS:528:DC%2BC3cXht1Krtr7N
-
Kang HJ, Shin HY, Park JE, Chung NG, Cho B, Kim HK, et al. Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: a phase II prospective multicenter study. Biol Blood Marrow Transplant. 2010;16:1582-8.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 1582-1588
-
-
Kang, H.J.1
Shin, H.Y.2
Park, J.E.3
Chung, N.G.4
Cho, B.5
Kim, H.K.6
-
248
-
-
84873443351
-
Management of acquired aplastic anemia in children
-
23292240 1:STN:280:DC%2BC3s3ntVGmug%3D%3D
-
Korthof ET, Békássy AN, Hussein AA. Management of acquired aplastic anemia in children. Bone Marrow Transplant. 2013;48:191-5.
-
(2013)
Bone Marrow Transplant
, vol.48
, pp. 191-195
-
-
Korthof, E.T.1
Békássy, A.N.2
Hussein, A.A.3
-
249
-
-
85027133880
-
Severe Aplastic Anaemia Working Party. Rabbit ATG for aplastic anaemia treatment: A backward step?
-
European Blood and Marrow Transplant Group
-
European Blood and Marrow Transplant Group. Severe Aplastic Anaemia Working Party. Rabbit ATG for aplastic anaemia treatment: a backward step? Lancet. 2011;378:1831-3.
-
(2011)
Lancet
, vol.378
, pp. 1831-1833
-
-
-
250
-
-
80052372971
-
Efficacy of rabbit antithymocyte globulin in severe aplastic anemia
-
21606164 1:CAS:528:DC%2BC38Xhs1KrtbzO 3166096
-
Afable MG 2nd, Shaik M, Sugimoto Y, Elson P, Clemente M, Makishima H, et al. Efficacy of rabbit antithymocyte globulin in severe aplastic anemia. Haematologica. 2011;96:1269-75.
-
(2011)
Haematologica
, vol.96
, pp. 1269-1275
-
-
Afable, M.G.1
Shaik, M.2
Sugimoto, Y.3
Elson, P.4
Clemente, M.5
Makishima, H.6
-
251
-
-
77955659229
-
Comparison between horse and rabbit antithymocyte globulin as first line treatment for patients with severe aplastic anemia: A single-center retrospective study
-
20373101 1:CAS:528:DC%2BC3cXpt1OitL0%3D
-
Atta EA, Dias DS, Marra VLN, de Azevedo AM. Comparison between horse and rabbit antithymocyte globulin as first line treatment for patients with severe aplastic anemia: a single-center retrospective study. Ann Hematol. 2010;89:851-9.
-
(2010)
Ann Hematol
, vol.89
, pp. 851-859
-
-
Atta, E.A.1
Dias, D.S.2
Marra, V.L.N.3
De Azevedo, A.M.4
-
252
-
-
82255188435
-
Increasing the dose of rabbit-ATG does not lead to a higher response rate in the first-line treatment of severe aplastic anaemia
-
Halkes CJM, Brand A, von dem Borne PA, Marijt EW, Willemze R, Veelken J, et al. Increasing the dose of rabbit-ATG does not lead to a higher response rate in the first-line treatment of severe aplastic anaemia. Bone Marrow Transplant. 2011;46(1 Suppl):S373.
-
(2011)
Bone Marrow Transplant
, vol.46
, Issue.1
, pp. 373
-
-
Halkes, C.J.M.1
Brand, A.2
Von Dem Borne, P.A.3
Marijt, E.W.4
Willemze, R.5
Veelken, J.6
-
253
-
-
84862548491
-
Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party
-
22544699 1:CAS:528:DC%2BC38XovFantLY%3D
-
Marsh JC, Bacigalupo A, Schrezenmeier H, Tichelli A, Risitano AM, Passweg JR, et al. Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party. Blood. 2012;119:5391-6.
-
(2012)
Blood
, vol.119
, pp. 5391-5396
-
-
Marsh, J.C.1
Bacigalupo, A.2
Schrezenmeier, H.3
Tichelli, A.4
Risitano, A.M.5
Passweg, J.R.6
-
254
-
-
84884673981
-
Effectiveness and safety of rabbit anti-thymocyte globulin in Japanese patients with aplastic anemia
-
23963878 1:CAS:528:DC%2BC3sXhtlalurfJ
-
Sakamoto T, Obara N, Kurita N, Sakata-Yanagimoto M, Nishikii H, Yokoyama Y, et al. Effectiveness and safety of rabbit anti-thymocyte globulin in Japanese patients with aplastic anemia. Int J Hematol. 2013;98:319-22.
-
(2013)
Int J Hematol
, vol.98
, pp. 319-322
-
-
Sakamoto, T.1
Obara, N.2
Kurita, N.3
Sakata-Yanagimoto, M.4
Nishikii, H.5
Yokoyama, Y.6
-
255
-
-
79961116424
-
Horse versus rabbit antithymocyte globulin in acquired aplastic anemia
-
21812672 1:CAS:528:DC%2BC3MXpvFSgsrc%3D 3721503
-
Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu CO, et al. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med. 2011;365:430-8.
-
(2011)
N Engl J Med
, vol.365
, pp. 430-438
-
-
Scheinberg, P.1
Nunez, O.2
Weinstein, B.3
Scheinberg, P.4
Biancotto, A.5
Wu, C.O.6
-
256
-
-
84862184679
-
EBMT Autoimmune Disease Working Party (ADWP); Paediatric Diseases Working Party (PDWP). Haematopoietic SCT in severe autoimmune diseases: Updated guidelines of the European Group for Blood and Marrow Transplantation
-
22002489 1:STN:280:DC%2BC38zmsFCnsg%3D%3D 3371413
-
Snowden JA, Saccardi R, Allez M, Ardizzone S, Arnold R, Cervera R, et al. EBMT Autoimmune Disease Working Party (ADWP); Paediatric Diseases Working Party (PDWP). Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2012;47:770-90.
-
(2012)
Bone Marrow Transplant
, vol.47
, pp. 770-790
-
-
Snowden, J.A.1
Saccardi, R.2
Allez, M.3
Ardizzone, S.4
Arnold, R.5
Cervera, R.6
-
257
-
-
84861802589
-
European Blood and Marrow Transplantation Group; Center for International Blood and Marrow Research; HSCT in MS International Study Group. A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A position paper
-
22383228 1:STN:280:DC%2BC38vltVygsA%3D%3D 3389500
-
Saccardi R, Freedman MS, Sormani MP, Atkins H, Farge D, Griffith LM, et al. European Blood and Marrow Transplantation Group; Center for International Blood and Marrow Research; HSCT in MS International Study Group. A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. Mult Scler. 2012;18:825-34.
-
(2012)
Mult Scler
, vol.18
, pp. 825-834
-
-
Saccardi, R.1
Freedman, M.S.2
Sormani, M.P.3
Atkins, H.4
Farge, D.5
Griffith, L.M.6
-
258
-
-
36549078572
-
Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation
-
17827036
-
Strober S. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation. Blood Cells Mol Dis. 2008;40:48-54.
-
(2008)
Blood Cells Mol Dis
, vol.40
, pp. 48-54
-
-
Strober, S.1
-
259
-
-
38549134052
-
Tolerance and chimerism after renal and hematopoietic-cell transplantation
-
18216356 1:CAS:528:DC%2BD1cXhtFShs7o%3D
-
Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Millan MT, Shizuru JA, et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med. 2008;358:362-8.
-
(2008)
N Engl J Med
, vol.358
, pp. 362-368
-
-
Scandling, J.D.1
Busque, S.2
Dejbakhsh-Jones, S.3
Benike, C.4
Millan, M.T.5
Shizuru, J.A.6
-
260
-
-
84860433872
-
Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants
-
22405058 1:CAS:528:DC%2BC38Xptl2hsLo%3D 3338901
-
Scandling JD, Busqueb S, Dejbakhsh-Jones S, Beniked C, Sarwale M, Millanb MT, et al. Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transplant. 2012;12:1133-45.
-
(2012)
Am J Transplant
, vol.12
, pp. 1133-1145
-
-
Scandling, J.D.1
Busqueb, S.2
Dejbakhsh-Jones, S.3
Beniked, C.4
Sarwale, M.5
Millanb, M.T.6
-
261
-
-
84910107208
-
Preliminary data of controlled randomised study (EVER TWIST) on tolerance induction
-
Libetta A, Canevari M, Margiotta E, Martinelli C, Borettaz I, Esposito P, et al. Preliminary data of controlled randomised study (EVER TWIST) on tolerance induction. Transpl Int. 2011;26(Suppl 2):20.
-
(2011)
Transpl Int
, vol.26
, Issue.2
, pp. 20
-
-
Libetta, A.1
Canevari, M.2
Margiotta, E.3
Martinelli, C.4
Borettaz, I.5
Esposito, P.6
-
262
-
-
0038298787
-
Tolerogenic immunosuppression for organ transplantation
-
12737859 2999636
-
Starzl TE, Murase N, Abu-Elmagd K, Gray EA, Shapiro R, Eghtesad B, et al. Tolerogenic immunosuppression for organ transplantation. Lancet. 2003;361:1502-10.
-
(2003)
Lancet
, vol.361
, pp. 1502-1510
-
-
Starzl, T.E.1
Murase, N.2
Abu-Elmagd, K.3
Gray, E.A.4
Shapiro, R.5
Eghtesad, B.6
-
263
-
-
38549088096
-
HLA-mismatched renal transplantation without maintenance immunosuppression
-
18216355 1:CAS:528:DC%2BD1cXhtFCjsrg%3D 2819046
-
Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med. 2008;358:353-61.
-
(2008)
N Engl J Med
, vol.358
, pp. 353-361
-
-
Kawai, T.1
Cosimi, A.B.2
Spitzer, T.R.3
Tolkoff-Rubin, N.4
Suthanthiran, M.5
Saidman, S.L.6
-
264
-
-
64749084427
-
C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus
-
19366777 1:CAS:528:DC%2BD1MXksVyksLY%3D
-
Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, Barros GM, et al. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA. 2009;301:1573-9.
-
(2009)
JAMA
, vol.301
, pp. 1573-1579
-
-
Couri, C.E.1
Oliveira, M.C.2
Stracieri, A.B.3
Moraes, D.A.4
Pieroni, F.5
Barros, G.M.6
-
265
-
-
34247154341
-
Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus
-
17426276 1:CAS:528:DC%2BD2sXktFeitL0%3D
-
Voltarelli JC, Couri CE, Stracieri AB, Oliveira MC, Moraes DA, Pieroni F, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA. 2007;297:1568-76.
-
(2007)
JAMA
, vol.297
, pp. 1568-1576
-
-
Voltarelli, J.C.1
Couri, C.E.2
Stracieri, A.B.3
Oliveira, M.C.4
Moraes, D.A.5
Pieroni, F.6
-
266
-
-
84881023549
-
Altering the course of type 1 diabetes: An update on prevention and new-onset clinical trials
-
1:CAS:528:DC%2BC3sXhsFajtrbJ
-
Thomas HR, Gitelman SE. Altering the course of type 1 diabetes: an update on prevention and new-onset clinical trials. Pediatr Diab. 2013;14:311-21.
-
(2013)
Pediatr Diab
, vol.14
, pp. 311-321
-
-
Thomas, H.R.1
Gitelman, S.E.2
-
267
-
-
84859508819
-
Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome
-
22360602 1:CAS:528:DC%2BC38XptVGkt7c%3D 3924750
-
Kadia TM, Borthakur G, Garcia-Manero G, Faderl S, Jabbour E, Estrov Z, et al. Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome. Br J Haematol. 2012;157:312-20.
-
(2012)
Br J Haematol
, vol.157
, pp. 312-320
-
-
Kadia, T.M.1
Borthakur, G.2
Garcia-Manero, G.3
Faderl, S.4
Jabbour, E.5
Estrov, Z.6
-
268
-
-
67650921718
-
Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome
-
19242494 1:CAS:528:DC%2BD1MXoslOhs7Y%3D
-
Garg R, Faderl S, Garcia-Manero G, Cortes J, Koller C, Huang X, et al. Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome. Leukemia. 2009;23:1297-302.
-
(2009)
Leukemia
, vol.23
, pp. 1297-1302
-
-
Garg, R.1
Faderl, S.2
Garcia-Manero, G.3
Cortes, J.4
Koller, C.5
Huang, X.6
-
269
-
-
33745255150
-
Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: The evolution from myeloablative to lymphoablative transplant regimens
-
17133541
-
Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F, et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum. 2006;54:3750-60.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 3750-3760
-
-
Burt, R.K.1
Marmont, A.2
Oyama, Y.3
Slavin, S.4
Arnold, R.5
Hiepe, F.6
-
270
-
-
35748953121
-
Treatment of autoimmune disease with rabbit anti-T lymphocyte globulin: Clinical efficacy and potential mechanisms of action
-
17911443 1:CAS:528:DC%2BD2sXht1Git7jP
-
Lytton SD, Denton CP, Nutzenberger AM. Treatment of autoimmune disease with rabbit anti-T lymphocyte globulin: clinical efficacy and potential mechanisms of action. Ann N Y Acad Sci. 2007;1110:285-96.
-
(2007)
Ann N y Acad Sci
, vol.1110
, pp. 285-296
-
-
Lytton, S.D.1
Denton, C.P.2
Nutzenberger, A.M.3
|